About COVAX

A historic multilateral effort co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organization (WHO) and UNICEF from 2020 through 2023, COVAX pushed to centre vaccine equity at the heart of the global response to the COVID-19 pandemic. COVAX will come to a close on 31 December 2023.

OWP logo

 

COVAX in numbers

Participants 195 participating economies
Delivery ~2 billion vaccines and safe injection devices shipped to 146 economies
Pandemic ~2.7 million deaths averted
Vial 10 different COVID-19 vaccine products shipped
Petri dish >US$ 12 billion to support access for lower-income economies

History and milestones

“No one is safe until everyone is safe”: Key moments in the evolution of the COVAX Facility – the global risk-sharing mechanism for pooled procurement and equitable distribution of vaccines at the heart of COVAX.

See timeline

Key learnings

View page

COVAX: key learnings for future pandemic preparedness and response

WHITE PAPER | 14 September 2022

Drawing on COVAX’s unique experience enabling an unprecedented global rollout at scale during a pandemic, this paper outlines the key challenges the mechanism faced in seeking to ensure equitable access to COVID-19 vaccines, the actions it took in response and recommendations for the future.

Download

A preliminary assessment of COVAX’s impact in lower-income countries

A preliminary assessment of COVAX’s impact in lower-income countries

WHITE PAPER | May 2023

Approximately 90% of COVAX-delivered COVID-19 doses have gone to lower-income economies. This represents the fastest and most complex global deployment of vaccines ever. But in terms of achieving equitable access during this pandemic, how successful has it been and where have its impacts been the greatest?

Download

Coordination in a crisis: Lessons managing the COVAX Strategic Coordination Office (2021–2023)

Coordination in a crisis: Lessons managing the COVAX Strategic Coordination Office (2021–2023)

WHITE PAPER | December 2023

Drawing upon experiences gained during the COVID-19 pandemic in coordinating the COVAX Strategic Coordination Office (SCO), this paper proposes lessons for future pandemic responses, as well as what might be maintained during intra-pandemic periods, to better prepare for future emergencies.

Download

Building an emergency response decision-making framework for outbreaks of pandemic potential

Building an emergency response decision-making framework for outbreaks of pandemic potential

DISCUSSION PAPER | April 2023

When an outbreak of an infectious disease starts to escalate, how should global health organisations decide on if, when and how to launch a response? To this end, Gavi is working with partners to develop a decision-making framework for outbreaks of pandemic potential that will define optimum interventions, specific to the outbreak, and unlock critical financing in response.

Download

The African Vaccine Manufacturing Accelerator: what is it and why is it important?

The African Vaccine Manufacturing Accelerator: what is it and why is it important?

VACCINESWORK ARTICLE

A new innovative financing instrument, called the African Vaccine Manufacturing Accelerator (AVMA), has been approved by the Gavi Board. But why is it important for African countries to produce vaccines, how will it work, and why now?

Read article

View page

Expanding Sustainable Vaccine Manufacturing in Africa 2022

WHITE PAPER | 2 November 2022

The pandemic has highlighted new and pressing challenges to regional vaccine supply resilience as a critical factor in global health security. While 1.8 billion doses1 of COVID-19 vaccine have been shipped under COVAX, including 0.6 billion to Africa, early delays in obtaining doses on the African continent stimulated new resolve to address future supply security.

Download

View page

A New Era of Vaccine Manufacturing in Africa

WHITE PAPER | 22 June 2022

One of the prominent issues exposed by the COVID-19 pandemic is the urgent need to further diversify global vaccine manufacturing, particularly with regards to Africa. With the political realities of nationalism, trade barriers, and the absence of regional manufacturing capability and capacity, rapid and equitable global access to life-saving vaccines can be compromised, leading to delays that put lives at risk.

Download

View page

Taking stock of humanitarian access to pandemic vaccines

DISCUSSION PAPER | 22 June 2022

COVAX was launched in 2020 with equity as its foundational principle, and fundamental to its design from the outset was a vision to address the most unpredictable and hardest to fill gaps in global COVID-19 vaccine access.

Download

View page

10 Learnings for the Alliance from the COVAX Humanitarian Buffer

DISCUSSION PAPER | February 2023

The following 10 learnings highlight the ways in which the COVAX Humanitarian Buffer (HB) and COVAX’s broader learnings in reaching humanitarian settings can contribute to both the Alliance’s work in routine immunisation, future preparedness and response efforts.

Download

Country perspectives

Reaching Every Child with the COVID-19 Recovery Fellowship in Ghana

A COVID-19 Recovery for Routine Immunization Fellowship is helping Evans Attivor successfully reach those who missed immunizations.

COVID-19 vaccination in pregnancy protects newborns

Research highlights the importance of maternal vaccination to protect infants against severe COVID-19 until they are old enough to be vaccinated themselves.

Five key factors that allowed COVAX to deliver two billion COVID-19 vaccines

The COVAX Facility set up to ensure that COVID-19 vaccines got to the most vulnerable, no matter where they lived, was unprecedented, and evolved many times over the pandemic. Here are five key factors that led to one of the biggest emergency…

Long COVID patients need scientific ambition, not defeatism

Post-viral illnesses have often been neglected by science. Insights into Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show that this is the time to ramp up efforts.

New evidence confirms COVID-19 vaccination in pregnancy is safe for babies

The largest study to date suggests that receiving an mRNA-based COVID-19 vaccine in pregnancy may be associated with fewer general complications during birth.

Cognitive slowness could be used as a marker for Long COVID

Diagnostic markers of Long COVID are rare, but a study of cognitive response might have uncovered one.

Lessons from Lower-Income Countries’ COVID-19 Vaccination Efforts

As the world prepares for the next pandemic, it will be crucial to learn from the innovative and tailored strategies that lower-income countries used to immunize hard-to-reach communities against COVID-19. These efforts offer insights into how to…

Could long covid ‘brain fog’ be an acquired form of ADHD?

ADHD usually manifests in childhood. But what if Covid-19 has shown that such neurodiversity can develop at any age?

What COVID diaries have in common with Samuel Pepys’ 17th-century plague diaries

Keeping a diary has been a common pandemic pastime throughout history.

Seven things you need to know about the JN.1 COVID-19 variant

WHO has designated the JN.1 form of Omicron a “variant of interest”, due to its rapidly increasing spread.

The Viral Most Wanted: The Coronaviruses

Seven members of the Coronavirus family are already known to infect people, often with deadly consequences. Disease investigators fear that more new and dangerous Coronaviruses could spill over at any time.

People who experienced childhood adversity had poorer COVID-19 outcomes, new study shows

People with adverse experiences during childhood − whether physical, emotional or sexual abuse − had higher rates of death and hospitalization decades later from COVID-19.

Nearly half of COVID-19 survivors in Africa experiencing Long COVID symptoms, study suggests

Fatigue is the most commonly reported symptom among COVID-19 survivors in Africa.

Getting the jab made simple in Eswatini

The Kingdom of Eswatini has made access to COVID-19 vaccination almost as easy as getting a headache pill. 

Leading on vaccine equity: reflections on 100 days as interim CEO

The interim CEO of the Vaccine Alliance looks back on his first 100 days and looks forward to the challenges ahead.

Facemasks catch viruses – so why is the evidence on their effectiveness so confusing?

When it comes to assessing the efficacy of facemasks some types of trial are better than others, experts say.

To Prevent the Next Pandemic, Follow the Science

The COVID-19 pandemic has underscored the critical role of evidence-based policies in addressing global health crises. It has also highlighted the need for flexible strategies, equitable health care, and multidisciplinary approaches that bridge…

From a Grassroots Survey to Long COVID Treatment Trials

A pharmacist polled patients on their dozens of medications and supplements. Could these efforts help fight long Covid?

Uzbekistan prepares for a viral winter

“Get vaccinated!” advises the government, as spikes in both flu and COVID-19 anticipated.

You’ve heard of long COVID, but did you know there might also be a long cold?

COVID isn’t the only respiratory disease to leave the patient with long-term symptoms. Colds and flu can do the same.

The hidden crisis: How the COVID-19 pandemic is impacting youth mental health

We are facing a parallel pandemic of mental health issues, particularly among young people. As with COVID-19 itself, prevention could be better than cure.

In Bangladesh, COVID-19 vaccines were a ticket back to independence for underprivileged ‘third gender’ people

Legally recognised but socially and economically marginalised, trans Bangladeshis encountered COVID-19 as an acute existential threat.

From Kraken to Pirola: who comes up with the nicknames for COVID-19 variants?

Professor Ryan Gregory is part of the team of COVID-19 sleuths who propose unofficial nicknames for Omicron variants.

Why do so many people hate wearing masks?

Some refused to believe they protected against COVID-19, others protested in violent anti-mask demonstrations. Why have face masks caused such extreme reactions?

From masks to testing: three key lessons we’ve already forgotten from the pandemic

The world wasn’t prepared for COVID-19 and painful lessons had to be quickly learned. But in moving on, there are important things we have already forgotten.

Will COVID-19 boosters protect against new variants such as “Pirola” and “Eris”?

The emergence of new Omicron subvariants has prompted fears about a fresh wave of infections, but existing COVID-19 booster vaccines are expected to provide reasonable protection against severe disease.

Why we still need to talk about pandemics and how to approach future ones

Nobody can be blamed for not wanting to hear the word ‘pandemic’ ever again. COVID-19, the worst global health emergency in 100 years, claimed the lives of millions of people.

Nearly a third of hospitalised COVID-19 patients show signs of organ damage

Study highlights the need to follow up COVID-19 patients after hospital discharge, especially if they have ongoing symptoms.

Will we see a return to masks and lockdowns against COVID-19 this winter?

As COVID-19 cases start to rise in the northern hemisphere and new data indicates that non-pharmaceutical interventions were effective in cutting cases, could we see a return to winter restrictions? 

Everything you need to know about the new BA.2.86 “Pirola” variant

The latest heavily mutated SARS CoV-2 variant has now been detected in 11 countries. Should we be worried?

COVID: should we start wearing masks again?

Some experts are calling for a return to masking as new variants emerge.

Standing Strong and Brave, Amid Strife

In this photo essay photographer Guerchom Ndebo and the WHO’s Eugene Kabambi capture resilience and community effort in the DRC’s IDP camps.

Five things you need to know about the ‘Eris’ COVID-19 variant

WHO has upgraded the EG.5 sub-variant to a ‘variant of interest’ although the public health risk remains low.

Could cellular energy factories hold the key to understanding Long COVID?

SARS-CoV-2 virus appears to disrupt genes in cellular energy factories called mitochondria, interfering with metabolism.

Disability in a pandemic – Africa’s forgotten families

Challenges for disabled people worsened with the COVID-19 pandemic and urgent attention is needed. But the pandemic worsened such challenges, especially in employment and accessing information. African governments should urgently implement…

What We Must Learn from COVID-19

With the pandemic now seemingly in the rearview mirror, policymakers must start preparing for the next public-health crisis. Today’s political leaders have a historic opportunity to foster a more inclusive global order, and they have a…

Failing to protect health care workers comes at too great a cost

The COVID-19 pandemic was a disaster. It led to at least 6 million deaths, caused tremendous economic and social disruption, and unwound decades of development gains in vulnerable lower-income countries.

Long COVID: brain function still affected for some up to two years after infection – new research

We used a series of ‘brain training’ style tasks to assess how a COVID infection and persistent symptoms affected cognitive function.

How Tanzania leapfrogged into the lead on COVID-19 vaccination

In January 2022, just 2.8% of Tanzania was vaccinated against COVID-19. A year and a half later, the majority of Tanzanians have completed their “primary series.” VaccinesWork asked experts what made all the difference.

A decade of partnership turns COVID-19 vaccination challenges into long term local solution in Laos

A long-standing partnership in Laos helped overcome challenges during COVID-19 vaccine introduction and led to long-term solutions that continue to support health workers with routine immunisation.

COVID-19 vaccines can provide critical protection for children

As SARS-CoV-2 is still circulating around the world, a study in The Lancet provides evidence that vaccination is a highly effective way to protect children from COVID-19.

“The Alliance never rests”: A preview of what’s coming at next week’s Gavi Board meeting

The Gavi Board, which brings together stakeholders from across the world of immunisation1, is meeting next week in Geneva. Prof. Jose Manuel Barroso, Chair of the Board, reflects on some of the key elements up for discussion.

“World’s largest brothel” pushed into crisis by COVID-19 lockdowns, bounces back with vaccination

COVID-19 had a devastating effect on Daultadia in Bangladesh, one of the world’s largest brothels. But special inclusive vaccination drives have offered the 1,500 sex workers living here a path to immunity, and back to normalcy.

Game changers: Nigerian states develop special initiatives to boost COVID-19 vaccination coverage

Five states in Nigeria have reached their COVID-19 vaccination coverage targets. VaccinesWork spoke to health leaders in three of them to learn how it’s done.

“Faces are like water in my head”: What happens when COVID-19 affects the brain?

Scientists are increasingly recognising that COVID-19 can have lasting and debilitating neurological symptoms, as well as causing structural changes to the brain.

Thousands of people in the UK are out of work due to long COVID

Studies from multiple countries have found that long COVID is linked to an increased likelihood of not working. Here’s what’s happened in the UK.

Global health progress has stagnated, putting countless lives at risk, WHO warns

The annual WHO Health Statistics Report says the COVID-19 pandemic has contributed to the ongoing decline in progress towards meeting the Sustainable Development Goals.

COVID fatigue: cognitive behavioural therapy could help people manage persistent symptoms – new research

Could CBT, a widely used form of ‘talking therapy’, help people who have persistent fatigue after having COVID? A recent study suggests it could.

Obesity speeds up loss of immunity from COVID vaccines – new research

We found the protection offered by COVID vaccines wanes more quickly in people with severe obesity compared to those of normal weight.

“We need these jabs”: How a Ugandan ‘bingwa’ is helping boost demand for COVID-19 vaccines

Amid flagging demand, Doreen Naiga – one of Africa CDC’s COVID-19 vaccination champions – is persuading young folks and persons with comorbidities in Uganda to get immunised.

COVID-19 is no longer a Public Health Emergency of International Concern. Does this mean the pandemic is over?

The WHO has lifted “PHEIC” status for COVID-19, but insists the disease continues to pose a global threat.

Indian data sheds new light on severity of “Arcturus” infections

A study from Maharashtra suggests the XBB.1.16 COVID-19 variant is replacing all other co-circulating lineages in India, but that the severity of infection is similar to other Omicron sub-variants.

Why finding moments of joy is important in chronic illness

Chronic illnesses like Long COVID can be devastating as people’s lives become radically smaller, but searching out joy and positivity can have real clinical benefits. 

Three countries that have seen the impact of COVID-19 vaccine delivery funding

More than US$ 1 billion has been approved by Gavi for 87 COVAX-supported lower-income countries to help them deliver COVID-19 vaccines to every corner of their countries. Here are three examples of where this funding is making a difference.

Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths?

The XBB1.16 variant may be the most transmissible version of SARS-CoV-2 yet, but experts believe it is unlikely to cause a big wave of cases.

Down – not out: COVID-19 cases surge in India

A rising immunity wall means cases are milder than they once were. But the steep recent spike, accompanied by the reimposition of mask mandates in some places, is a reminder that the pandemic bug is still stalking us.

Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest”

Reports of itchy eyes and high fever are triggering alarm, but there is still nothing to indicate that XBB.1.16 will trigger an increase in hospitalisations or deaths at this stage.

COVID-19 vaccine coverage continues to increase in lower-income countries

The COVAX facility has shipped nearly two billion doses worldwide, ensuring health care workers and older people in low-income countries are protected against a virus that is still claiming lives across the world.

Creating new norms in Ghana with human-centred design

By mid-2022 only 36% of the eligible population in Ghana had been vaccinated against COVID-19. The latest behavioural science techniques helped turn the tide.

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

A vaccine produced by Sanofi is being given as part of the 2023 spring booster campaign. An immunology expert explains how it works.

Q&A: COVID lessons could ease cholera outbreak – Moeti

Lessons from COVID-19 pandemic could ease Africa’s cholera outbreak, says WHO’s Matshidiso Moeti

Why focusing on COVID deaths undercounts the health harms of the pandemic – new research

A new study has attempted to quantify the pandemic’s effects on global health by surveying people across 13 countries.

The COVID pandemic risks lasting damage to adult social care

The COVID pandemic has left lingering consequences both for people receiving adult social care and support in England, and for the workforce delivering it.

Omicron Soup: Deciphering WHO’s new COVID-19 labelling system

WHO has simplified its variant labelling system, but stresses that Omicron remains a public health threat.

A Path Out of the Pandemic

Although the mRNA vaccines have done an excellent job of reducing COVID-19 hospitalizations and deaths, questions remain regarding waning immunity, and public uptake has decreased with each new booster. With the pandemic still far from over, a…

Could the common cold give children immunity against COVID? Our research offers clues

Certain immune cells acquired from a coronavirus that causes the common cold appear to react to COVID – but more so in children that adults.

Could drugs to prevent Long COVID finally be within reach?

Two new studies have suggested that existing diabetes and antiviral drugs could be repurposed to prevent symptoms of COVID-19.

What next-gen Covid-19 vaccines might look like

From building up defenses in the nose to slowing down a virus’s ability to make copies of itself, scientists are rolling out a raft of creative approaches to fighting infection.

“We need to reach every child”: How Uganda’s routine immunisation program climbed back from COVID-19

Resilience can look like a canny financial strategy or a health worker crawling up a rickety ladder, finds John Agaba in Kampala.

Wisma Mugano: A village health worker’s dedicated life of service

Village health workers, like Mugano, have been instrumental in delivering health services to people in hard-to-reach areas and ensuring that no one is left behind.

Snow-capped peaks and ice-lined refrigerators: extending the cold chain far into Nepal’s Himalayas

Reliable transportation and electricity can be a tall order in the high mountains, but investments in the cold chain have brought vaccines several steps closer to the community. 

Do a Quarter of Kids Really Get Long Covid? It’s Complicated.

While the numbers are hard to pin down, some researchers say their colleagues have overstated the risks.

COVID, bird flu, mpox – a virologist on why we’re seeing so many viruses emerge

It’s likely a combination of the incidence of viral outbreaks increasing, and the fact we’re getting better at detecting them.

An immunologist’s reflections on nine months of long COVID

In 2022, Dr Stéphanie Longet got COVID-19 and then Long COVID. Here, Longet, who studies vaccine-induced immunity, talks to VaccinesWork about her mission to understand the condition better.

#VaccinesWork’s top 10 Long COVID stories

Long COVID has altered the lives of millions of people, all living in the limbo of experiencing COVID-19 symptoms weeks or months after their initial infection, yet not knowing how or when they will recover. On International Long COVID Awareness…

Three years on, the COVID pandemic may never end – but the public health impact is becoming more manageable

The WHO first described COVID as a pandemic on March 11, 2020. Where are we at, three years later?

A fighting chance: translating routine vaccination for Kakuma’s multilingual refugee population

Sometimes to build demand for vaccines, just speaking the right language can be enough, especially in one of the world’s largest refugee camps.

COVID poetry: how a new genre is helping readers to comprehend the pandemic

Many established poets published lockdown poems offering their perspective on the power of poetry to make sense of the pandemic.

8 things we have learned from the COVID-19 pandemic

Next week marks three years since the World Health Organization characterised COVID-19 a pandemic. From immunity and vaccine efficacy to virus evolution and Long COVID, here’s what we now know.

In Ghana, a game of post-pandemic immunisation catch-up is being hobbled by vaccine shortages

Closing the COVID-19 immunity gap to make sure Ghana’s children are protected is only possible when there are enough vaccines in clinic refrigerators.

Q&A: How to fix the worst malnutrition crisis in more than 40 years

Climate change, COVID-19 and the Ukraine war’s impact on food prices are combining to create the worst hunger crisis in decades. VaccinesWork spoke to Simon Bishop, CEO of the Power of Nutrition, about why this matters, and what we need to do to…

Sri Lanka was winning its battle with leprosy. Then came COVID-19

Slowly, but hidden behind the disruptive pandemic virus, leprosy was spreading. Now Sri Lanka’s health department is working hard to find and cure a cohort of patients before it’s too late.

“No mean feat”: India reaches more than 100 million teens protected against COVID-19

It began at a sprint, and it’s slowed to a stroll – but there are signs that India’s campaign to vaccinate its colossal adolescent cohort is making steady gains among initially hesitant parents.

Why does it feel like everyone is sick at the moment?

Instead of thinking we’re paying an ‘immunity debt’ after the lockdowns of the pandemic, it would be far better to focus on the best way to robustly and safely boost our immune systems: vaccination.

Target single men to counter new COVID-19 variants, health survey of more than 45,000 people reveals

Research across 67 countries shows single men were more inclined to ignore anti-Covid measures than their female or married peers. To face off new variants, health campaigns need to target them.

New roadmap charts a course towards improved coronavirus vaccines that could head off future threats

An international collaboration of scientists has mapped out a strategy to make long-lasting and broadly protective coronavirus vaccines a reality.

How much immunity do we get from a COVID infection? Large study offers new clues

Previous infection was highly protective against reinfection with alpha, beta and delta variants, but less so against omicron BA.1.

Can the “world’s first intranasal COVID vaccine” help spur booster uptake in India?

Physicians say they hope the needle-free jab will fuel booster demand, helping squash transmission of the pandemic virus.

Which lower-income countries saw the biggest COVID-19 vaccination coverage gains in 2022?

Throughout 2022 COVAX helped lower-income governments to roll out jabs and launched an initiative to help those furthest behind improve. So which countries made the biggest strides in coverage? The answer may be surprising.

“Every aspect of sexual and reproductive health is impacted”: The hidden toll of Ebola

As an obstetrician working in Sierra Leone just as the 2014-16 Ebola epidemic was taking off, Dr Benjamin Black found himself at the frontline of an unfolding health crisis. He recently published a book about his experiences, and explains how…

Genetics might explain why some people have never had COVID – but we shouldn’t be too focused on finding out

Scientists are trying to find out whether there’s a genetic reason certain people have managed to avoid COVID for three years.

How an Apostolic women’s group helped Zimbabwe counter vaccine hesitancy

Zimbabwe’s large Apostolic faith community has a reputation for shunning medical intervention, including vaccination. Amid COVID-19, that position began to soften. Here, insiders tell VaccinesWork about the strategies that made a difference.

Burundi’s COVID-19 vaccination campaign accelerates

With just 0.25% of the country immunised, Burundi is dangerously behind the rest of the world when it comes to protection from the pandemic virus. But, a revamped strategy is pushing the pace of vaccination. 

Yes, masks reduce the risk of spreading COVID, despite a review saying they don’t

An updated Cochrane Review suggests face masks don’t reduce the spread of COVID in the community. But there are several reasons why this conclusion is misleading.

COVID-19 is still a global health emergency. What does that mean?

We've just passed the third anniversary of the declaration of the COVID-19 emergency – and WHO says it’s not over yet. Let’s talk about it.

What happens when you don’t recover from COVID-19?

During the early months of the COVID-19 pandemic, the main focus of public health systems was on avoiding hospitalisation and death. Yet the lingering effects of SARS-CoV-2 infections are something we should all be worried about, even if our…

Vaccine hesitancy in South Africa: COVID experience highlights conspiracies, mistrust and the role of the media

Curbing vaccine hesitancy is as much a matter of acknowledging its social, historical, and cultural roots as it is of addressing its clinical dimensions.

Long COVID has had a brutal effect on the workforce, study finds

The post-viral condition has prevented significant numbers of employees from returning to work, especially women and those aged over 60 or with co-morbidities.

Signs of progress: interpreters combat misinformation among Nigeria’s hearing-impaired

When a rumour threatened to derail COVID-19 vaccine uptake in Lagos’s hearing-impaired community, a small cohort of sign language interpreters stepped up to help them separate fact from fiction.

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.

“Fighting on two fronts”: battling HIV/AIDS amid COVID-19 in Pakistan

HIV infections in Pakistan are rising. HIV/AIDS workers and activists say that community-based service provision is improving – but that more help is needed.

LGBTQI organisations campaign for COVID-19 vaccination in Eswatini

Discrimination is deadly, especially amid a pandemic. In Eswatini, LGBTQI organisations are making sure that COVID-19 vaccines reach a community often left behind by mainstream healthcare.

Nepal reckons with COVID-19’s steep toll on mental health

Nepal’s commitment to providing mental health care is growing. But resources remain scarce, and rates of mental illness are spiking.

The costly lesson from COVID: why elimination should be the default global strategy for future pandemics

An upgraded global response to future potential pandemic threats would give the best chance of eliminating new infectious diseases at source before they spread globally.

A “tripledemic” of viruses is fuelling a surge in pneumonia, but what are the symptoms to look out for?

RSV, influenza and COVID-19 can all trigger pneumonia. Here’s what you should know about this lung infection.

Breathing Life Back into COVID Prevention

Taking the fight to pathogens like the coronavirus will require a multi-pronged strategy to improve air quality in indoor public and private spaces. And though this method of prevention will require new investments, the costs will pale in…

Q&A: Africa’s new order for achieving health security

Fully implement Africa’s new public health order for better health outcomes, says Africa CDC’s acting director.

COVID and your gut: how a healthy microbiome can reduce the severity of infection – and vice versa

The microbes in our gut have many roles, including to support immune function.

How Botswana, a self-financing COVAX country, solved its pandemic strategy puzzle

If anyone knows that a radically inclusive health agenda can rout a rampant virus, it's Botswana. That's part of why, in 2020, the government "jumped at" the chance to join COVAX, Health Minister Edwin Dikoloti tells VaccinesWork. But that was…

Colds, flu and COVID: how diet and lifestyle can boost your immune system

Here are some simple things you can do everyday to help your immune system fight off infections.

Here’s what we know about the new Omicron variant XBB.1.5

A new subvariant of Omicron that caused a spike in cases in the northern hemisphere last winter is spreading like wildfire across the world, but how worried should we be?

How COVID can disturb your sleep and dreams – and what could help

If you’ve had trouble sleeping during or after a COVID infection, you’re not alone.

How Bangladesh’s immunisation system is coming back stronger

Has COVID-19 taught a cohort of Bangladeshis the value of vaccination?

Sehat Kahani is showing Pakistan that digital health services can change lives – for both patients and doctors

The healthcare app is giving sidelined women physicians a way to practise, and isolated communities a network of experts to turn to.

Five things to know about Long COVID and chronic fatigue syndrome

Scientists are looking into the similarities between Long Covid and chronic fatigue syndrome (CFS) – also known as myalgic encephalitis (ME). Here is what we know so far. 

Flu spikes in Indian Kashmir as COVID-19 measures lift

In the wake of the COVID-19 crisis, uptake of the flu vaccine in the Himalayan state appears to be unusually slow. But as temperatures plummet and masks are left at home, that’s having contagious consequences. 

University clinics move beyond the student population in Zambia

The clinics on Zambia’s university campuses go beyond catering simply to academics’ and students’ health needs.

Renewed malaria push needed after COVID-19 setback

New tools are urgently needed to fight malaria following disruptions to eradication efforts, say health leaders.

Hello, 2023: Gavi’s Board votes in a plan for the coming year

Here are six of the vaccine organisation’s top priorities for a brand new ”Year of Renewal”.

Overweight women may be at highest risk of long COVID – new research

A new study of people in England sought to understand what factors make people more or less susceptible to developing long COVID.

COVID deepened inequalities in HIV treatment: what we learnt in Nigeria

Some vulnerable populations may have fallen through the cracks despite efforts to improve access to HIV services during the pandemic in Nigeria.

Previous COVID infection may not protect you from the new subvariant wave. Are you due for a booster?

The next COVID wave has already hit our shores. Make sure you check whether you’re recommended for another booster dose of vaccine.

Long COVID stigma may encourage people to hide the condition

A UK survey found most long COVID sufferers have experienced discrimination, prejudice or shame related to the condition.

So worth it: COVID vaccination generated tenfold return on investment in New York

Vaccinating against COVID-19 saves lives. It can also save healthcare systems considerable amounts of money, study finds.

The World Is Still Failing at Pandemic Preparedness and Response

The G20 and international financial institutions still have not created a pandemic preparedness and response framework capable of managing the next global health crisis. Fortunately, some low- and middle-income countries are pioneering new models…

COVID, flu, RSV – how this triple threat of respiratory viruses could collide this winter

Outbreaks of seasonal diseases like flu and RSV, along with a further COVID-19 wave, could lead to another public health disaster, warn experts.

Self-financing COVAX champions: Lebanon

Getting COVID-19 vaccines to all countries, whether or not they could afford them, was critical early in the pandemic to stop the virus spreading. This is Lebanon’s experience of being a self-financed partner in COVAX.

Does a faint line on a COVID-19 test mean I’m no longer infectious?

Rapid antigen or lateral flow tests can help to identify when someone with COVID-19 is most infectious, but even a faint line should be treated as a positive result.

COVID: inhalable and nasal vaccines could offer more durable protection than regular shots

These types of vaccines could offer certain advantages over conventional COVID shots. But we need more data to show us they’re effective.

In rural north India, school teachers prescribe a tweaked curriculum against further pandemic disruption

Where online learning is not an option, school doors have to remain open. The best way to make sure they do? Lessons on health, hygiene and vaccination.

Here's how to approach flu shots and COVID boosters during pregnancy

COVID-19 and flu vaccinations are safe in all trimesters during pregnancy, medical experts say. Bivalent boosters can also be given during pregnancy.

Ebola in Uganda: lessons from COVID show that heavy-handed lockdowns may be a bad idea

Lockdown measures may stop the spread of the virus. But they can also lead to a larger and more protracted public health crisis in the form of deprivation and hunger.

How anthropology can bring the human element to emergency outbreak response

Technical solutions to a health emergency risk failing if they don’t allow communities their say; this is where anthropologists come in.

COVID vaccines don’t just benefit physical health – they improve mental health too

The mental wellbeing benefits associated with COVID vaccination were substantial among older and clinically vulnerable people, but negligible for younger adults.

Long COVID: how lost connections between nerve cells in the brain may explain cognitive symptoms

Many people face persistent cognitive symptoms after COVID-19. A new study, which grew and examined 3D models of the human brain, offers a possible explanation as to why this might be.

Five reasons why COVAX supports all nations

Since January 2021 COVAX has shipped more than 1.8 billion COVID-19 vaccines to 146 nations across the globe. Ninety percent of these doses have gone to lower-income countries and territories, but why does COVAX’s model also support higher-income…

Worried about side effects after a COVID-19 shot? Here’s why you probably don’t need to be

Rather than causing any concern, a new study suggests mild post-vaccination symptoms can be signals of vaccine effectiveness, and reinforces the importance of boosters in older people.

COVID and health workers’ strike: how Kenya’s health services coped in times of crisis

Outpatient visits, screening and diagnostic services, and child immunisation were particularly negatively affected.

Ebola in Uganda: why women must be central to the response

As with Ebola, it is often only when the harm is done that people working on the response realise health emergencies disproportionately harm women.

Four ways to support a friend or loved one with long COVID

Start by creating a safe space by showing you beleive them.

Is it wise to get a COVID-19 booster and a flu vaccine at the same time?

Studies suggest that combining influenza and flu vaccination is safe and any increase in side effects is mild.

COVID has taken a greater toll on mental health among people from ethnic minorities – sadly this is no surprise

A recent study tracked depression and anxiety among participants from across different ethnic backgrounds in the US and the UK.

Life expectancy still not recovered from COVID-19 in many countries

COVID-19 caused the biggest mortality shock since World War 2, and many countries’ life expectancy rates are languishing still.

Book Excerpt: It’s not just humans at risk from COVID-19

To believe the coronavirus was engineered to target humans is to ignore its broad capacity for infecting other animals.

Ramping up Africa’s vaccine manufacturing capability is good for everyone. Here's why

Africa only produces about 0.1% of the global supply of vaccines – a market failure which has cost lives and needs urgent attention. Creating greater vaccine supply resilience for Africa through domestic production requires creating a multi-…

Talking vaccines door to door: Community outreach drives up COVID-19 vaccine coverage in Kwara, Nigeria

Kwara State’s health workers are going door to door to spread accurate information about COVID-19 vaccines. The approach is working.

The gateway to all vital health interventions

A progressive universalism approach to health care would prioritise immunisations for children, offering the fastest and most effective way to cover lost ground in global public health – and helping to bring universal health coverage within reach…

Five things you need to know about COVID-19 vaccines and your period

Data shows that getting vaccinated can temporarily affect your period, but that the change is temporary.

5 things to know about COVAX in September 2022

September saw good progress in history’s largest vaccine rollout, with COVID-19 vaccine coverage continuing to increase in lower-income countries and civil society finding its voice. Managing Director of the COVAX Facility, Dr Derrick Sim, gives…

Five takeaways from WHO’s immunisation advisory committee

Last week WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization met to discuss COVID-19 boosters, monkeypox, Ebola, polio and measles, among other concerns. Here’s what they decided.

My third COVID-19 infection: Why reinfection can be anything but mild

Vaccination and natural immunity have dramatically reduced the death toll from COVID-19, but catching COVID-19 for a third time is still no walk in the park, as Linda Geddes discovered last week.

COVID-19 has turned back decades of progress on reducing maternal and child deaths

New research has revealed the impact of healthcare disruption during the pandemic on maternal and child health. The Global Financing Facility’s Tashrik Ahmed and Bruno Rivalan discuss the implications.

Community health workers as vaccinators: A pathway to achieving global immunisation goals

A shortage of health workers has made the roll-out of COVID-19 vaccines in many lower-income countries a major challenge. In Malawi, community health workers are helping to fill the gap.

Some coronaviruses kill, while others cause a common cold. We are getting closer to knowing why

The enigmatic envelope protein seems to hold the key to understanding why some human coronaviruses cause more severe disease than others.

How women’s cooperatives in India emerged as COVID-19 first responders

Integrating COVID-19 campaigns into the work that the Self-Employed Women’s Association does ensured that rural communities were not left out.

Japan invests to ensure pandemic vaccines can be made in 100 days

The country will put US$ 2 billion in a research initiative to help turn a vaccine around at speed when the next pandemic comes along.

COVID and the cost of living crisis are set to collide this winter – the fallout will be greatest for the most vulnerable

If governments fail to take action, the cost of living crisis will worsen the impact of the pandemic this winter, and vice versa.

Nepal integrates hygiene promotion with routine immunisation

Communities in Nepal combined sanitation awareness campaigns with routine immunisation during the pandemic. It might just have helped them keep COVID-19 under control.

Smartwatches could help detect and track COVID – here’s what the research shows

Smartwatches could provide an extra line of defence to help us keep COVID and other infectious diseases at bay. Here’s what the evidence says.

What’s really happening with global vaccine access?

A new scorecard offers insights at a glance from the country to global level.

Hunting for Pi – the next variant after Omicron – in the toilet

Tracking the circulation of infectious diseases through wastewater is not new, but it’s becoming vital in the hunt for the next version of COVID-19.

Has the pandemic changed our personalities? New research suggests we’re less open, agreeable and conscientious

COVID-related changes in our personalities could go some way to explaining the widespread decrease in wellbeing.

APR 2021: 1.2 million future deaths prevented, 65 million children newly protected

Gavi’s 2021 Annual Progress Report, released today, is a record in numbers of another difficult pandemic year – a year of alarming setbacks, and a year of hard-won gains.

APR 2021: Recognising country commitment

Prof José Manuel Barroso, Chair of the Gavi Board, reflects on the achievements of lower-income countries during the pandemic.

APR 2021: Reflecting on 2021, the global imperative for 2022

Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, looks back on the first year of Gavi 5.0

COVID: how ICUs in England were stretched to cope with the pandemic

Here’s what happened behind the scenes to increase intensive care capacity at the height of the pandemic.

COVID-19 vaccination in India’s remote villages

Health workers and religious heads have joined forces to ensure that Kargil’s remote villages are vaccinated against COVID-19.

Preparing for the Next Global Catastrophe

The end of the pandemic may be in sight, but COVID-19 could be a harbinger of future calamities. If global leaders do not establish equitable mechanisms to respond before the next big crisis strikes, low-income countries and high-risk groups will…

COVID pandemic created immunisation gaps in Africa. Over half a million children are at risk

The pandemic has disrupted national immunisation programmes. As a result, the African continent is seeing more outbreaks of vaccine preventable diseases.

7 COVAX innovations that could help us fight the next pandemic

With 1.7 billion doses delivered to more than 140 countries and territories, COVAX is the largest, most complex vaccine rollout in history. The innovations made along the way could play an important role in fighting the next pandemic.

Conspiracy theories are dangerous even if very few people believe them

Worrying about how many people believe false ideas misses the real danger – that people are influenced by them whether they believe them or not.

COVID-19 vaccination protects against Long COVID

UK data indicates that even though vaccinated people may have breakthrough infections, they are at less risk of developing Long COVID than those who are not vaccinated.

The WHO has advised against the use of two antibody therapies against COVID – here’s what that means

This guidance replaces previous conditional recommendations for the use of these drugs and is based on emerging evidence that they’re not likely to work against omicron.

Supporting vaccination: a toolkit for community health workers

A free digital toolkit that equips health workers to drive greater vaccine understanding and uptake around the world.

New survey suggests reinfection worsens Long COVID

Survey indicates that getting reinfected worsens symptoms of Long COVID or triggers a recurrence of symptoms in people who have recovered.

Mental health conditions raise risk of Long COVID

New data indicates that people reporting depression, anxiety and stress before a COVID-19 infection are 50% more likely to report Long COVID symptoms.

Another new COVID variant is spreading – here’s what we know about omicron BA.4.6

BA.4.6 seems to be even better at evading our immune response than BA.5.

How long after I get COVID-19 will I test negative?

Testing positive for COVID-19 – even without symptoms – can be disruptive to daily life, but how long should we expect to test positive for?

First published on 29 October 2021, updated on 13 September 2022

UNGA: getting back on track to the global goals

As world leaders gather in New York for the 77th United Nations General Assembly, why should we focus to re-commit to vaccine equity, routine immunisation and pandemic preparedness that learns from COVID-19?

Misinformation is a common thread between the COVID-19 and HIV/AIDS pandemics – with deadly consequences

The spread of misinformation in many pandemics, including the smallpox and 1918 influenza outbreaks, have undermined efforts to contain infections and prevent deaths.

Long COVID takes hold in Nigeria

Health workers are not resting on their oars to care for Long COVID patients in Lagos, Nigeria. They have set up a clinic and are undertaking awareness talks.

Why health budgets must not be cut amidst political and economic turmoil

We must protect health budgets to safeguard our populations and ensure that our health systems are resilient to inevitable future challenges. Healthier populations are happier, more productive and take an active role in the workforce. We must…

How African countries coordinated the response to COVID-19: lessons for public health

Combining several layers of response to COVID-19 was effective. Decentralisation, innovation and building on existing systems were key.

Unraveling the Interplay of Omicron, Reinfections, and Long Covid

The omicron variant has proved adept at finding hosts, often by reinfecting people who recovered from earlier bouts of covid. But whether omicron triggers long covid as often and severe as previous variants is a matter of heated study.

Five reasons to wear a mask even if you don’t have to

Even though the pandemic is far from over, mask mandates are being lifted across the world. But here is why you shouldn’t bin your mask just yet.

First published on 25 April 2022, updated 7 September 2022

With a little help from friends, officials keep COVID-19 vaccinations going in Ghana

Health officials at district level are serving as examples to the rest of Ghana with their approach to COVID-19 vaccination.

Got allergies? You could be at lower risk of catching COVID

Evidence has shown that people with allergies and asthma are at lower risk of contracting COVID-19. Here’s why we think this might be.

Islamic organisations promote COVID-19 vaccinations in Indonesia

To tackle the COVID-19 pandemic, Islamic organisations are not only promoting vaccinations but also administering them.

New study suggests risk of extreme pandemics like COVID-19 could increase threefold in coming decades

Researchers estimate we currently face a 2% chance of a COVID-19-like pandemic in any given year. Climate change is increasing this risk.

Lower back pain could affect up to a quarter of COVID-19 survivors

Clinics should prepare for an increase in people seeking treatment for lower back pain in the aftermath of COVID-19 infection, researchers warn.

5 things to know about COVAX in August

Here’s the first of a series of monthly round-ups giving a status update on the historic effort to ensure equitable uptake of COVID-19 vaccines across the world.

New research suggests COVID-19 vaccines can slow the spread of disease, even with Omicron

A study of SARS-CoV-2 transmission shows the importance of vaccination in reducing the risk of transmission and cutting COVID-19 cases.

‘Tomato flu’ outbreak in India – here’s what it really is

Swabs from two children in the UK reveal the cause of the ‘mysterious illness’.

Bangladesh’s success in dealing with COVID-19

A quick response, early drive for vaccines, proper campaign management and mass participation have helped Bangladesh fully vaccinate more than 70% of its population against COVID-19.

Multilateral action can turn blueprints for equity during future pandemics into reality – the industry’s proposal

Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), explains how the biopharmaceutical industry’s Berlin Declaration will help the world’s most vulnerable populations.

We can repair broken global solidarity and accelerate efforts toward COVID-19 vaccine equity

Inequity in access to COVID-19 medical countermeasures continues to be the bane of the global response to this pandemic.

Nepal braces for a fourth wave

Having vaccinated over 80% of its population, Nepal is prioritising children five and above, and the unvaccinated, to head off a possible fourth wave of COVID-19.

Eating less food from animal sources is key to reducing the risk of wildlife-origin diseases and global warming

Infectious diseases originating in wild animals are high and may be increasing. This is a sign that ecosystem degradation is undermining the planet’s capacity to sustain human wellbeing.

How COVID-19 lockdown measures — and their outcomes — varied in cities around the world

Examining how COVID-19 lockdowns and stay-at-home orders were implemented in Toronto, Johannesburg and Chicago reveals the impact they had on vulnerable communities.

Quelling the pandemic in the world’s largest refugee camp

As part of its national COVID-19 vaccination programme, Bangladesh is making sure that the Rohingya people aren’t left out.

Routine immunisation amidst the COVID-19 pandemic

A new policy brief outlines key learnings from a webinar series hosted by the Gavi CSO Constituency in collaboration with RESULTS UK, UNICEF, Save the Children, USAID, Geneva Learning Foundation and Gavi, the Vaccine Alliance.

We studied how COVID affects mental health and brain disorders up to two years after infection – here’s what we found

People who get COVID continue to face increased risks of developing some neurological and psychiatric conditions, like psychosis and dementia, for up to two years afterwards.

Seven photos of health workers in action: World Photography Day 2022

A celebration of the stories of care and commitment, captured in images of healthcare workers in action, from many corners of the globe. 

Testimonies on the heightened COVID-19 vaccination among refugees

Voices of refugees, host community, health workers and experts speak about COVID-19 vaccination.

Malawi health workers lead in COVID-19 vaccination

Malawi has vaccinated 83% of its frontline health care workers against COVID-19, pushing them to the forefront of the country's vaccination efforts.

“Pakistan can”: How one country repaired its routine immunisation safety net

As the COVID-19 pandemic hit in early 2020, Pakistan’s routine immunisation programme took a heavy hit. But while many countries continued to struggle to make up lost ground in 2021, Pakistan bounced back to pre-pandemic levels of protection.…

The race to understand long-COVID in children

Around ten percent of children and young people develop persistent symptoms after their initial COVID-19 infection. Dr David Warburton of Children’s Hospital Los Angeles explains how the US National Institutes of Health’s RECOVER COVID initiative…

Long COVID affects one in eight, says Lancet study

New data indicates that while fatigue, muscle pain and breathing difficulties have risen even in non-infected people over the pandemic, a significantly higher proportion of people with COVID-19 develop persistent Long COVID symptoms.

New COVID variants could emerge from animals or from people with chronic infections – but it’s not cause for panic

Animal reservoirs and people who experience chronic COVID infections could potentially see the emergence of new variants. But these variants aren’t necessarily cause for concern.

Biosecurity Is National Security

Just as the advent of the information age underscored the need for cybersecurity, the growing threat of infectious diseases should spur significant investments in biosecurity. To prevent future pandemics, we must be as focused on adapting and…

Surge in cases prompts vaccine drive and return to mask-wearing in Kenya 

A surge in COVID-19 infections has prompted a mass vaccination drive throughout Kenya.

Centaurus: what we know about the new COVID variant and why there’s no cause for alarm

A new COVID variant, BA.2.75, has been detected in the UK and several other countries. But the data we have at the moment doesn’t suggest there’s any reason to panic.

How can we boost COVID-19 vaccine coverage in lower-income countries?

COVID-19 vaccine coverage in low- and middle-income countries is increasing at a steady pace, but remains lower than higher-income nations. VaccinesWork spoke to Ted Chaiban, Head of the COVID-19 Vaccine Delivery Partnership, about how…

Masks are ‘strongly suggested’ by health authorities as the winter COVID wave hits. Here’s how effective they are

They’ve stopped short of mandates, but authorities and experts are strongly suggesting it’s time to cover our mouths and noses again to prevent COVID infection. This time, reach for a respirator.

Theatre steps up to change perceptions about vaccines in Kashmir

When the majority of North Kashmir’s Bandipore villages showed reluctance to get vaccinated against COVID-19, a local theatre came forward to win over hearts and minds.

Mobile vaccinators offer a lifeline to people with disabilities in Eswatini

With support from Médecins Sans Frontières, mobile teams of vaccinators are helping vulnerable groups in Eswatini get protected against COVID-19.

How the COVID-19 pandemic has affected healthcare around the world

New insights into the disruption caused by COVID-19 could help strengthen health systems ahead of future pandemics.

Health Workers Fill the Gaps for Millions of Zimbabwean Villagers

The workers play a pivotal role in the country’s health system, providing care and fighting misinformation.

Long COVID: with no treatment options, it’s little wonder people are seeking unproven therapies like ‘blood washing’

Long COVID patients are taking desperate measures in the hope of getting better. It’s time to increase our focus on testing potential long COVID treatments in clinical trials.

COVID: risk of diabetes and heart disease is higher after infection – but maybe only temporarily

A new study analysed data from hundreds of thousands of COVID patients in the UK.

Q+A: How CEPI-funded research is supporting the COVID-19 vaccine rollout

More data is needed to better understand how COVID-19 vaccines work in different populations and to know what size and order of shots works best. CEPI’s Director of Clinical Development, Jakob Cramer, discusses the research CEPI is supporting to…

Mask mandates – will we only act on public health advice if someone makes us?

If our immunity from COVID vaccines is waning, then wearing a mask to prevent infection is even more valuable. But not many people seem to be thinking that way when they’re out and about.

‘Time to invest in genomics’ in poorer countries – WHO

Genomics has been crucial in COVID-19 response, driving research. But many poor countries lack access to the technology. First WHO Science Council report makes recommendations to address barriers.

Omicron WHAT? A users’ guide to COVID-19 variant names

A Twitter user has nicknamed the latest Omicron subvariant “Centaurus”, and it has quickly gone viral. So, is it time to rethink the COVID-19 variant naming system?

Safari doctors take to the waters to save lives in Kenya

Lamu County islands are accessible only by boat. Getting health services to them is a unique challenge.

COVID vaccines and pregnancy: a review of the evidence shows they are safe

In all the research reviewed, none found any safety concerns regarding COVID vaccines during pregnancy.

Could a variant-proof coronavirus vaccine be within reach?

Tests in non-human primates suggest Caltech’s Mosaic-8 vaccine triggers broad immune responses against a spectrum of different SARS-like viruses.

Many people are still shielding from COVID – and our research suggests their mental health is getting worse

While the general public has become less anxious over the course of the pandemic, the opposite is true for vulnerable people who have been shielding, a new study suggests.

COVID reinfections could be more severe for some – but overall evidence doesn’t give us cause for concern

Intuitively, we would assume that subsequent infections should be less severe. But this won’t always be the case.

COVID vaccines: our current shots could soon be updated to target new variants – an immunology expert explains

Is it time for a new generation of COVID vaccines? Here’s where the research is at.

COVID vaccines work well for people of all body weights – but underweight and obesity remain risk factors for severe disease

A new study looked at the health records of more than 9 million people in England to assess whether body weight influenced the uptake and effectiveness of COVID vaccines.

Long COVID: female sex, older age and existing health problems increase risk – new research

A new study has analysed UK data from long-term health surveys and electronic health records to understand how common long COVID is, and who might be at higher risk.

The stark reality of how COVID-19 has worsened global inequality

The toll of the pandemic has been hardest on the most vulnerable, pushing millions into poverty and leaving them more at risk of disease, hunger and violence.

COVID-19 vaccines have saved 20 million lives so far, study estimates

Deaths from COVID-19 were two-thirds lower than they otherwise could have been during the first year of the vaccination programme, mathematical modelling suggests.

How bad is the fresh wave of COVID-19 infections being driven by the BA.4 and BA.5 variants likely to be?

Various countries are experiencing an uptick in COVID-19 cases driven by the highly transmissible BA.4 and BA.5 Omicron sub-variants, so what should we expect in the coming weeks?

Telemedicine booms in India

The telemedicine boom in India is making city-level health facilities accessible to people in the remote hilly and tribal areas of the country.

Overcoming hesitancy, one vaccination at a time

Faced with a third coronavirus wave in the DRC, health workers are mobilizing daily to promote vaccination and fight against disinformation.

Four ways you can design social media posts to combat health misinformation

It’s one thing to get ‘likes’ on a video of a cute dog or a photo of your weekend adventures – but another to create content that fosters understanding of complex topics.

Long COVID and the workplace: What employers could do better

Globally, an estimated 200 million people are living with ongoing COVID-19 symptoms, many of them in the prime of their working careers. So, what can businesses do to support them and help themselves? UK human resources professional Lesley…

The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases

Two years ago, the Recovery trial transformed COVID treatments around the world with a landmark finding that may have saved a million lives in just nine months.

The need for culturally sensitive COVID-19 vaccine campaigns in sub-Saharan Africa

Better strategies are needed to overcome vaccine hesitancy, but these need to be tailormade for regions.

Hybrid immunity: a combination of vaccination and prior infection probably offers the best protection against COVID

‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.

How digitisation is ensuring no child is left behind

A technology NGO is replacing paper vaccination records with simple, cost-effective technical solutions in the Gambia and Uganda.

COVID: six ways long-term smell loss can affect you

Many people have been left with longer-term impairments to their sense of smell following COVID.

COVID-19 greatly increases risks to pregnant women: largest sub-Saharan study

A large six-country study in Africa shows that pregnant women are more likely to be admitted to intensive care or to die if they have COVID-19, indicating the importance of vaccination.

COVID vaccines for children under five: what parents need to know

Pfizer and Moderna have both recently reported results for their COVID-19 vaccines in the youngest children.

South Sudan expands access to COVID-19 testing and vaccinations

A COVID-19 vaccination and health centre in Northern Bahr el Ghazal is reaching the most marginalised and vulnerable.

Future COVID-19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge

A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.

How to improve primary healthcare to prepare for future pandemics

These are some of the pivotal areas we need to invest in to build better health systems.

AI drives quest for new antivirals to fight outbreaks

Lack of antiviral candidates limited the fight against COVID-19. Consortium aims to develop new oral antivirals for coronaviruses, dengue and Zika. But critics highlight lack of representation from low-and middle-income countries.

How Indonesia got vaccinated

With 95% of the population now jabbed against COVID-19, Indonesia’s vaccine campaign has trounced pessimistic early forecasts.

Why health care is still not inclusive enough, and what we can do to change it

Many LGBTQI+ people are excluded from health care services such as vaccination because of discrimination, social stigma or outdated gender-identification systems, but there are moves to change this.

Embracing the science of vaccines: Tanzania’s changing COVID-19 response

Amid a broad-based effort to sort vaccine fact from vaccine fiction, health workers and community leaders in Tanzania are noticing a change in attitudes among young and old.

Trendspotting: why pandemic preparedness needs to include big data

Professor Marion Koopmans has been instrumental in investigating the animal origins of everything from bird flu to COVID-19. She is now looking at how we can prevent the next pandemic.

Papua New Guinea looks to rebuild its small business sector

The PNG government is looking to stimulate the small business sector by injecting funds into the economy.

The last to receive COVID vaccines are the hardest and most critical to reach

There must be a way to help people cover gaps in health care costs without forcing them to be public about their most private concerns.

COVID-19 could derail SDGs for next five years – report

COVID-19 will remain uncontrolled in many countries unless coordinated action is taken, warn scientists. SDGs progress was already lagging before the pandemic. Inequities in all sectors must be addressed to avoid worst-case scenario. UN…

The pandemic is far from over: how can the private sector help us fight it?

We are still in the acute phase of the pandemic, with cases continuing to rise in many countries and vaccination rates stagnating. The private sector could play a key role in finally bringing COVID-19 under control.

Funding the Polio Eradication Endgame

The US Centers for Disease Control and Prevention warns that cutting back on eradication efforts could cause a global resurgence of polio that ten years from now could paralyze up to 200,000 children a year. The final five-year push to eradicate…

Why does COVID-19 cause back pain?

Increasingly, people who get COVID-19 are reporting they have back pain. We look at how common this is and what might be behind it.

CoughWatch: Meet the South African researchers tracking COVID-19

Mvuyo Makhasi is leading a team tracking the pandemic via a novel digital platform – CoughWatchSA.

“The Cure Is Us”: Kibera artists take on the pandemic

In a bid to build awareness around COVID-19, Uweza Foundation and Safe Hands Kenya are tapping into the power of art.

75th World Health Assembly High Level Messages

The 75th World Health Assembly (WHA) is taking place in Geneva from 22–28 May. Here are the key recommendations and messages Gavi will be bringing to the global health leaders and other health stakeholders gathering at the WHA.

Haven’t had COVID yet? It could be more than just luck

Even taking into account people who have had COVID but didn’t know it, there’s still likely to be a group of people who have never been infected.

Taking COVID-19 vaccines to the slums of Lagos

The Lagos state government is working hard to give residents of Kotomallam, a slum in Ojota, access to COVID-19 vaccines.

Nepal’s transgender community gets vaccinated

A rigid male/female ID system in Nepal was preventing many members of the country’s transgender community from getting the COVID-19 jab. A group of activists, working with the government, is turning things around.

Children’s physical activity dropped during COVID lockdowns but didn’t bounce back – new UK research

A new study looks at UK kids’ physical activity levels once COVID restrictions had begun to lift compared with before the pandemic.

Fourth COVID-19 shot could give higher immunity than a third dose

Antibody levels after a second booster dose were higher than the peak level after the initial booster.

Taming the spike: How Jason McLellan helped turn the tide of the pandemic

The microscopic spikes on the SARS-CoV-2 virus are fundamental to its ability to infect us. Locking these shapeshifters in place would prove fundamental to developing vaccines against it.

Four strange COVID symptoms you might not have heard about

From skin lesions to hearing loss, unusual symptoms can be troubling for COVID patients.

Getting routine immunisation back on track in India

With the pandemic under relative control, India is getting back on track with its nationwide routine immunisation programme through Mission Indradhanush 4.0.

Long COVID: Wuhan patients still have symptoms two years later

Two years after COVID-19 infection, over half of people hospitalised are still experiencing at least one symptom, according to the longest follow-up study so far.

6 new breakthroughs in the fight against cancer

Cancer scientists are using AI, DNA sequencing, precision oncology and other tech to improve treatment and diagnosis of the disease. Here are 6 advances. Breakthroughs include the DNA sequencing of more than 12,000 cancer tumours and a new…

Five things we’ve learned about the BA.4 and BA.5 Omicron variants

The BA.4 and BA.5 Omicron sub-variants threaten to trigger a new wave of COVID-19 infections in South Africa. Here’s what we know about them so far.

How South Africa is integrating COVID into routine care for mothers and babies

The direct effects of COVID-19 disease on pregnant women, newborns and children are acknowledged. But the indirect effects of the pandemic have been equally devastating.

Five things you need to know about the SDGs – and how the pandemic has shifted the goalposts

The Sustainable Development Goals (SDGs) were created in 2015 as a holistic vision for transforming human development, but COVID-19 derailed progress – so how do we get back on track?

From war to the pandemic: a refugee in Nigeria changes the narrative

A Cameroonian refugee volunteer, one of more than 70,000 refugees living in Nigeria’s Cross River State, is fighting misinformation and helping to save lives in the camps.

Breathing New Life into Medical Oxygen

In low- and middle-income countries, the COVID-19 pandemic exposed a long-neglected problem that was already contributing to untold preventable deaths every year. Now, a global mobilization to scale up the supply of medical oxygen must be…

Severe COVID is equivalent to 20 years of ageing – new study

A new study finds that the cognitive loss from severe COVID is the same as losing 10 IQ points.

Slum-dwellers disproportionately affected by COVID-19, study suggests

People living in Brazilian slums died of COVID-19 at disproportionate rates – but redistributing intensive care beds to anyone in need has wider benefits.

Women’s water burden rose as COVID lockdowns hit

Rising demand for water collection in poor countries added to womens’ burden. Water, sanitation lacking in health, quarantine facilities – survey. School closures also limited access to these basic services for girls.

Misinformation on social media is linked to vaccine hesitancy, says study

Sharing false information, even when later debunked, correlates with people either delaying vaccination or refusing the vaccine outright.

Virus that causes COVID-19 can linger in digestive tract

New evidence indicates that SARS-CoV-2 can infect the gastrointestinal tract.

“Missing link” of RNA viruses found in oceans could detect emerging viral threats

An analysis of oceanic genetic material has identified 5,500 new viruses, which could give clues as to how these viruses affect organisms driving many of the ecological processes that control our planet.

A long life for all: let us realise this utopia, for all the children of Africa

Writing exclusively for VaccinesWork, H.E. Madam Auxilia Mnangagwa, on behalf of the Organisation of African First Ladies for Development1, closes World Immunization Week 2022 with one simple message: let's be grateful for…

Stormy weather: boat-borne vaccines ferry a dose of hope to the Sundarbans

In an ecosystem threatened by climate change, cyclones and COVID-19 have battered human health and livelihoods. Mobile healthcare is finding a way to navigate these intersecting crises.

‘Zero dose’ children: almost 14 million get no vaccines

Interview: Gavi Deputy CEO Anuradha Gupta says ‘zero dose’ children account for disproportionate number of early deaths

Applying the COVID Blueprint to Cholera

Despite their apparent differences, COVID-19 and cholera have much in common, which explains why measures to limit the former, such as decreased travel and increased attention to personal hygiene, brought about a decline in the latter. It also…

Can COVID-19 inspire progress in maternal immunisation?

Vaccination in pregnancy is a powerful public health tool, but underused. New insights from the pandemic may be just the spark needed to energise progress.

Q&A: Cold chain experts on keeping vaccines cool

The global COVID-19 vaccine rollout would not have been possible without cold chain equipment (CCE) keeping vaccines cool as they are transported and stored. We spoke to supply chain experts Karan Sagar and Shahrzad Yavari about why COVAX’s work…

New studies show empowering women can mean fewer children miss out on essential vaccines

Two new studies suggest that women’s education reduces the number of zero-dose children who never receive a single vaccine.

Gavi impact in Africa since 2000

Gavi’s mission is to save lives and protect people’s health by increasing equitable and sustainable use of vaccines. Our work is driven by country needs and priorities. Gavi supports countries to strengthen primary health care through innovative…

How to end the pandemic

WHO has outlined four potential scenarios for the future of COVID-19 and shared a strategy for how the world can end the acute phase of the pandemic.

How effective is a fourth dose of COVID-19 vaccine?

As some countries gear up to roll out a fourth dose of the vaccine to boost immune responses, data suggests it is not necessarily needed for everyone.

Effect of lockdowns on birth rates in the UK

Fertility rates declined among women of all ages in the UK at the start of the pandemic – but have been picking up again, particularly among older mothers.

Pandemic life on the Delhi Metro

Despite many challenges over the past two years, the Delhi Metro has developed a safe way to transport hundreds of thousands of people every day.

Africa’s Long Post-COVID Climb

While Africa shared in last year’s global economic upswing, a growing array of risks threatens to derail the region’s progress in 2022. The crucial question is whether the world’s leading central banks can pursue price stability without choking…

Disabled people are being left out of COVID recovery. Here are five ways to change that

Many people want to go ‘back to normal’, but this isn’t possible for many disabled people.

Hepatitis cases are increasing among children in the UK – could COVID have a role to play?

While COVID-19 hasn’t been ruled out as a potential cause, the leading contender is actually adenovirus, a common infection in children that can lead to hepatitis on rare occasions.

People who’ve had COVID appear more likely to develop diabetes – here’s why that might be

A number of recent studies indicate people who have had COVID are more likely to be diagnosed with diabetes.

Everything you need to know about COVID-19 antivirals

Several antiviral pills have now been authorised to treat COVID-19, but how do they work and will people in developing countries be able to access them?

India draws lessons from polio eradication initiative

The programme to eradicate polio shows that mass immunisation is possible in India.

Europe at risk of measles resurgence as COVID-19 restrictions are eased

With many countries failing to hit measles vaccine coverage targets, and COVID-19 control measures being lifted, the goal of measles elimination hangs in the balance.

The vaccinodromes of Kinshasa: DRC steps up COVID-19 vaccinations

The task is enormous: by the end of 2023, vaccinate 53 million Congolese. Despite the many challenges, the government is fine-tuning its strategy.

COVID-19 infection linked to high risk of blood clots for months afterwards

Scientists have identified a 33-fold increase in the risk of potentially fatal clots in the lungs, and a five-fold increase in the risk of deep vein thrombosis in the 30 days after catching COVID-19.

Sick words: The etymology of disease

What are we really saying when we utter a diagnosis?

How innovative financing will help prepare for future pandemics

COVAX, using an innovative finance model, has delivered over 1.2 billion doses to lower-income countries. Innovative financing models could equip governments worldwide to prepare for and mitigate future pandemics. Effective and sustainable…

Avoiding COVID Complacency

While wealthy countries ease COVID-19 restrictions and welcome a return to normal life, many low-income countries are still struggling to get vaccines into people’s arms. The longer they remain short of the 70% immunization target, the more…

We’re spending more years in poor health than at any point in history. How can we change this?

Life expectancy is rising, but we are also spending more time living in poor health. It doesn’t have to be this way, according to a new study* from the McKinsey Health Institute. Medical advances and lifestyle changes could give us an extra six…

Cow dung fires linked to black fungus epidemic in India

Cow dung is widely used in India as fuel, for medicines and in rituals. Medical researchers say cow dung is rich in black fungus spores. Spores released through smoke from cow dung fires spread widely.

‘Your driver is vaccinated’: How COVID-19 vaccines saved Delhi’s gig economy

Daily wagers have been able to get their jobs back following vaccination.

Caught COVID? Here’s what you should and shouldn’t do when self-isolation isn’t mandatory

The virus is still a threat – so be kind to yourself and others if you catch it.

Data-sharing in a pandemic: even though scientists shared more than ever, it still wasn’t enough

Although countries shared more genetic information on SARS-CoV-2 than in any other pandemic, too many have hidden data, hindering the search for the next variant.

Community voices boost vaccine messaging in Cape Coast, Ghana

Community leaders are taking it upon themselves to encourage people to get vaccinated.

What does “fully vaccinated” against COVID-19 actually mean?

With countries increasingly recommending third or even fourth doses of COVID-19 vaccines, how many vaccine doses will we ultimately need to remain protected against COVID-19?

Vaccines provide extra protection to those previously infected with COVID-19

Studies confirm importance of COVID-19 vaccination for people who have recovered from infection.

COVID reinfections: are they milder and do they strengthen immunity?

Here’s what we know so far about why reinfections happen and what effects they have.

Twelve million vaccinations in three days: how Bangladesh used a pandemic lull to shore up its defences. Credit: Gavi/2022/Saydul Fateheen Murad

Bangladesh’s COVID-19 fatality rates are at an all-time low – but that hasn't stopped the country’s vaccination programme from flooring the gas pedal.

How India overcame smallpox

India’s eradication of smallpox with a comprehensive vaccination campaign is the perfect case study for the current COVID-19 vaccine rollout.

Survey shows public want vaccines shared based on need and equity

A study published in Vaccine shows the public in Germany and US overwhelmingly want medical urgency and equal access prioritised when it comes to the global distribution of COVID-19 vaccines.

Even mild COVID can cause brain shrinkage and affect mental function, new study shows

Brain changes including shrinkage, weakened connections and poorer performance on thinking and memory tests could explain ‘brain fog’ after COVID – even after ‘mild’ cases.

“How long can I remain in isolation?” How COVID-19 vaccines helped reopen the schools of Kashmir

The response from students to a vaccination drive to re-open schools has been overwhelming.

What social media tells us about vaccine hesitancy

Government and scientific communications about COVID-19 vaccines are often discussed on social media, which can influence decisions to get vaccinated; here’s how governments need to use that understanding to better advocate for vaccines.

What is next week’s Gavi COVAX AMC Summit hoping to achieve?

The virtual event aims to raise at least US $3.8 billion from donors, as part of a wider US $5.2 billion package of support, to ensure that everyone everywhere has access to COVID-19 vaccines – here’s what those funds will be spent on.

How innovative finance helps close the vaccine equity gap

“Innovative Finance” has been working behind the scenes for decades, helping to raise billions of dollars for some of the world’s most important causes. But how does it actually work, and how is helping to close the vaccine equity gap?

Is the COVAX Facility ensuring equitable vaccine distribution?

A new study has looked into how effective COVAX has been in its central aim: reducing the disparity between rich and poor when it comes to access to COVID-19 vaccines.

"Flurona" co-infection increases the risk of severe illness and death

Worse outcomes for patients infected with COVID-19 and influenza highlight the importance of vaccination against both diseases.

Ending the COVID-19 pandemic means helping countries to catch-up with vaccination, not giving up

Like COVID-19, complacency can be contagious. Dr Seth Berkley argues that during a pandemic complacency can be very dangerous.

Protecting health on both sides of the zoonotic frontier: Dr Gladys Kalema-Zikusoka

Ugandan wildlife vet Gladys Kalema-Zikusoka knows that pathogenic threats move both ways across the human-animal boundary – and that the best way to protect both animals and people is to bring public health and conservation together.

Did the COVID lockdowns work? Here’s what we know two years on

Research shows that lockdowns helped control cases in general – but that not all control measures had the same effect.

The sewage sleuths turning Bangalore’s wastewater into epidemiological treasure

Wastewater surveillance is increasingly used to track COVID-19 infections and the spread of new variants. Linda Geddes speaks to Dr Angela Chaudhuri about the Bangalore-based initiative she helped establish, which she hopes could provide a…

Testing sewage has helped track COVID – soon it could reveal much more about the UK’s health

An unexpected legacy of COVID could be a new system for monitoring public health.

How virtual reality could help reduce vaccine hesitancy

A new study suggests that by engaging people in immersive, gamified experiences, virtual reality could drive home the importance of vaccination.

Vaccinating in the Indian Himalayas: local governments lead the charge

The Panchayat officials in Bir have played a key role in getting locals and tourists vaccinated against COVID-19.

The Subtle Psychology of ‘Nudging’ During a Pandemic

For years, the U.S. and U.K. governments embraced the concept of nudges to change social behavior. Then came Covid-19.

3 health lessons for business from the COVID-19 pandemic

The link between our physical and economic health was made painfully clear during the pandemic, but what lessons can businesses take forward from COVID-19?

Pakistan has vaccinated more than 80% of the adult population against COVID-19

In about 13 months, Pakistan has turned the vaccination tide, fuelled by the availability of adequate COVID-19 vaccine doses.

Pandemic parliaments: lessons learned from two years trying to run democracies living under COVID-19

Social distancing, lockdowns and emergency powers changed the way elected representatives operated in the pandemic.

Everything you need to know about Deltacron and other COVID-19 variants of concern

A hybrid of the Delta and Omicron COVID-19 variants, Deltacron may sound scary, but there is currently no reason for great concern.

The worst disaster in a generation: Cyclone Ana wreaks havoc on health in Malawi

Malawi is using mobile clinics to try to alleviate the effects of a tropical cyclone that hit the southern region of the country.

Pandemic hit the pause button on the discoveries of new species

The COVID-19 pandemic slowed down the progress of species discovery and documentation due to travel bans, restricted access to technology, and limited funding, according to researchers who work in leading biodiversity inventory projects across…

Could we get a pandemic vaccine in 100 days?

The first COVID-19 vaccines took a year – lightspeed by usual development standards – but global health experts believe we can go much faster.

Do contact-tracing apps have a future?

With COVID isolation scrapped in England, it’s unclear what’s next for the NHS’s much-discussed app.

COVID-19 vaccine roll-out continues amid torrential rains in Lesotho

Despite floods and landslides, Basotho are finding a way to get vaccinated.

Vaccinating people with disabilities in Kashmir

In Kashmir, a disability welfare organisation is ensuring that people with disabilities are not left behind.

Vaccines are being portrayed as limiting personal freedom – but this can mask the true reasons for hesitancy

Framing vaccines as an infringement of liberty is a powerful tactic, but obscures health and political factors that may actually drive resistance.

Is COVID-19 causing an anxiety epidemic?

A new Lancet Public Health study suggests the long-term impact of severe COVID-19 infections might not be limited to the physical symptoms of Long COVID.

How fractional dosing of COVID-19 vaccines could boost global supply

Halving the dose of some COVID-19 vaccines could provide an extra 0.5 billion doses each month, researchers suggest.

Vaccines without needles could have numerous benefits, but require further investment

Microarray patches could overcome many of the logistical obstacles hindering measles and rubella elimination, but manufacturing facilities are urgently needed to produce them.

Kenya’s HPV vaccine strategies re-activated for COVID-19

Strategies to ensure effective HPV vaccinations in Kenya have been modified to boost rollout of the COVID-19 vaccine.

Two years into the pandemic, which of our newly formed habits are here to stay?

COVID has disrupted how we work, socialise and shop, but there are some signs we’re returning to doing things like we used to.

Carrying the hopes of a nation on her back: Nepalese health worker goes above and beyond

Health worker Lila Thapa walked 30 minutes over hilly terrain with an elderly community member on her back, ensuring she received her COVID-19 vaccine.

Q&A: COVAX and the Humanitarian Buffer

Refugees, migrants in vulnerable situations, asylum seekers, stateless people and other populations of concern in humanitarian settings are at higher risk of being overlooked in the global COVID-19 vaccine roll-out. Learn what COVAX is doing to…

COVID: risk of severe disease could be in your blood, new research finds

Genetic research has linked a number of blood proteins to severe COVID – including the enzyme that determines your blood type.

“I didn’t give up”: Kashmir’s vaccinators brave the harsh winter

Snow and freezing conditions are not deterring Kashmir’s health workers from getting vaccines to the people.

Conclusions from the 22nd DCVMN Annual General Meeting

Last October vaccine manufacturers from developing countries across the world gathered with global health leaders to discuss vaccine inequity and ways to boost production globally. Here are the key takeaways.

Keeping vaccines cold

Walk-in coolers provided by the COVAX Facility are helping to strengthen vaccine storage facilities around Nepal – crucial as the country seeks to accelerate its ongoing COVID-19 drive.

International Women's Day 2022

For this year’s International Women’s Day VaccinesWork spoke to four women from across the globe who are leading the response to the pandemic.

COVID-19 prompts dramatic reduction in dengue fever

Schools and public areas could be dengue transmission hot spots, research suggests.

Mass COVID testing and sequencing is unsustainable – here’s how future surveillance can be done

Passive monitoring of the virus through wastewater or more targeted and evenly spread testing would be better than our current tactics.

Book Excerpt: The Lockdown Diaries of Wuhan

A delivery driver’s social media posts highlight the daily struggles of those confined during the pandemic.

Vaccine education: Rolling out COVID-19 vaccines to Pakistan’s schools

In Pakistan, educational institutions are convincing parents to get their children vaccinated against COVID-19 through motivational sessions and informative material.

The long haulers: what we now know about Long COVID

Long after the initial infection, millions continue to suffer the crushing fatigue, muscle, joint pain and breathlessness that Long COVID can bring – here’s what we know two years after the pandemic started.

No PCR, no problem: how COVID can be diagnosed with X-rays

X-ray scans are taken in hospitals worldwide – and an AI program has been taught to scan them for coronavirus.

Kenya’s Health Ministry partners with NGO to ramp up COVID-19 vaccination

The partnership with SHOFCO is expected to support the government’s push to administer 20 million jabs between January and June 2022, as well as keep routine immunisation going.

The animators of Nilgiri: Authorities turn to NGOs to bridge the trust gap in India

NGOs and local community leaders have helped turn the tide when it comes to vaccinations in the Nilgiri hills.

How the pandemic has affected periods

The coronavirus, vaccines and pandemic stress have all been linked to distributions to people's menstruation cycles.

Transgender and disabled communities leading the fight against the pandemic in Chennai

In the Indian city of Chennai, transgender and disabled communities have led the way in raising awareness of vaccination.

Kangaroo care saving babies’ lives in rural Kenya

Kangaroo care – close skin to skin contact with a baby from birth – is not only helping premature babies to survive in Eastern Kenya, it is also helping to change perceptions around COVID-19.

Eight changes the world needs to make to live with COVID

There's no going back to a pre-pandemic normal – only forward to a new one.

Vietnam vaccinates 90% of its population against COVID-19

In just five months, Vietnam has turned its COVID-19 vaccination drive around.

Compulsory vaccination helps conquer fears in Nigeria

Mandatory vaccination policy introduced by the Federal Government of Nigeria in all its public institutions has contributed to an increase in the number of vaccinated people.

Amid uncertainty, Pakistan is winning the battle against Omicron

Pakistan's government is working on a robust strategy to contain the spread of COVID-19 by rapidly scaling up immunisation in rural parts of the country.

Q&A: Science ‘needs to listen to African voices’

Public speaking a lifelong skill for scientists. Drive behind research should come from grassroots. Science and art merge together in field of communication.

What zero-COVID countries can teach the rest of the world

Most of the handful of countries pursuing zero COVID-19 cases are now starting to move towards cautiously living with the virus, but their efforts hold lessons for the rest of the world in a future where the virus is here to stay.

COVID: how will people behave when self-isolation isn’t mandatory?

People are less likely to isolate if they don't legally have to – but some still will voluntarily.

Study shows scaling up mRNA vaccines for lower-income countries is affordable and could save millions of lives

When it comes to COVID-19, no-one is safe until everyone is safe. A new study suggests vaccinating countries that haven’t had good access to vaccines so faris necessary to stop the virus continuing to evolve into new, potentially deadlier,…

Nurses in Lagos are going against all odds to improve neonatal and infant health care

Through dedication and commitment to service, nurses in Nigeria’s commercial hub, Lagos State, are working hard to improve routine immunisation.

COVID may have made us less materialistic – new research

For many, the pandemic switched the focus away from financial gain.

The Necessary Rise of Africa's Health Tech

The African health-care sector continues to struggle with a lack of resources and funding, but creative uses of technology offer new possibilities for improving access to medical treatment. Building on developments spurred by the pandemic, health…

Pandemic preparedness – preparing for the worst, hoping for the best

Every major outbreak of disease from Zika to Ebola has prompted reviews of the response. A new Lancet review looks at factors linked to the variety of COVID-19 case and death counts across the globe to guide investment into pandemic preparedness…

Social media helps boost vaccine coverage in Kenya

Social media and digital advertising has contributed to an increase in immunisation in Kenya.

What will COVID-19 look like in 2022?

It is tempting to think the worst of the pandemic is behind but the virus is still evolving and the future of COVID-19 is not clear cut. Here two of Gavi’s experts Dr Lee Hampton, medical epidemiologist, and Dr Gustavo Correa, Senior Manager for…

How new training approaches are transforming health workers’ ability to deliver vaccines

The pandemic made the challenge of training health workers in lower-income countries even harder. To counter the huge impact COVID-19 is having on health systems worldwide, a collaboration between Gavi and The Rockefeller Foundation is improving…

How can the world adapt to COVID-19 in the long term?

Covid-19 is here to stay. However, with careful management we can prevent future outbreaks and move from pandemic to endemic. But what does this mean, and what must we do to stop it from erupting again?

Can you be infected with COVID-19 without ever testing positive?

Most people who are infected with coronavirus develop symptoms, but not everyone does. So, what assumptions can you make about your level of immunity if you stay well when everyone around you has COVID-19?

COVID-19 could become endemic – here is what existing endemic diseases look like

COVID-19 becoming endemic is harder to define than you may think. Here we outline how to know when the virus becomes endemic and outline what existing endemic diseases such as malaria and TB look like.

How new COVID-19 variants emerge: Natural selection and the evolution of SARS-CoV-2

COVID-19 variants are the products of the evolution of the SARS-Cov-2 virus. They arise via mutations, but other forces also have roles to play in the generation and transmission of variants.

How to Make the Pandemic History

As the COVID-19 pandemic enters its third year, millions of people around the world remain in the grip of fear and uncertainty, owing to our collective failure to achieve universal vaccination. Still, three upcoming events offer world…

Vaccine mandate drastically increases vaccination rate in Nepal

To boost uptake, the Nepalese government has made vaccination cards mandatory for access to public services: it’s working.

Togo rolls out social safety net scheme to soften the economic impact of COVID-19

The arrival of COVID-19 into Togo in 2020 hit the economy, and ordinary people’s wallets, hard. The government stepped in to help.

The fair price shops of Uttar Pradesh, India

Uttar Pradesh’s fair price shops are helping improve vaccination rates amongst marginalised sections of the community.

Zimbabwe’s health workers on the pandemic front line

Health workers at the forefront of Zimbabwe’s COVID-19 vaccination campaign share their experiences.

What is the Novavax vaccine, and why does the world need another type of COVID-19 vaccine?

With doses of the Novavax vaccine now starting to be delivered around the world, we examine what difference it could make to the pandemic.

Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed?

One study suggests the virus takes an average of 36 days to clear from the body after symptoms first appear.

COVID-19 through the lens of a Ghanaian photographer

While the pandemic forced everyone else indoors, a Ghanaian photographer took to the streets to document Accra on lockdown.

COVID-19 survivors are still at greater risk of heart attacks a year after infection

Countries should be prepared for a surge in heart problems, suggests the most comprehensive study on COVID-19 and cardiovascular risk to date.

Vaccinating in Kenya’s remote Samburu and Turkana counties

The county governments in Samburu and Turkana have collaborated to ensure that villagers are vaccinated.

How do you vaccinate the world’s second largest country?

Despite the size of both the country and its population, India has vaccinated over three-quarters of adults against COVID-19. How has it managed it?

Preventing the next pandemic is vastly cheaper than reacting to it: Study

Humanity's response to pandemics to date is similar to our climate change response: mitigation rather than prevention. A new study says prevention could save trillions of dollars and millions of lives.

What deliberately infecting people with SARS-CoV-2 is teaching us about COVID-19

The first COVID-19 human challenge study is yielding new insights into how healthy young adults respond to infection.

How did Kenya surpass its 2021 COVID-19 vaccination target?

Kenya was aiming to reach 10 million people with COVID-19 vaccines by the end of December 2021. Thanks to a clear strategy, COVAX support and the hard work of thousands of health workers, they reached their target.

Fresh research says Omicron lasts much longer on surfaces than other variants – but disinfecting still works

We can't say whether longer Omicron survivability on surfaces relates to a greater risk of infection.

Q&A: The hunt for new COVID-19 variants

Dr Gabrielle Breugelmans is head of epidemiology at the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership launched in 2017 to develop vaccines to stop future epidemics. She explains how new COVID-19 variants are…

Could mRNA vaccines protect against HIV?

Moderna has begun a trial with an experimental HIV vaccine based on the same technology underpinning its COVID-19 vaccine.

What’s the best way to tackle COVID and climate change? Anthropology, says the woman who predicted the global financial crisis

Financial Times journalist and author Gillian Tett discusses her new book, Anthro-Vision: How Anthropology Can Explain Business and Life.

The Equity Agenda in Fourth Industrial Revolution Healthcare Technology

The COVID-19 pandemic has demonstrated the power of innovative Fourth Industrial Revolution (4IR) technologies in healthcare systems. Unless these technologies are designed with equity at their core, we risk leaving some people even further…

Myocarditis: COVID-19 is a much bigger risk to the heart than vaccination

Myocarditis following COVID-19 vaccination is rare, and the risk is much smaller than the risks of cardiac injury linked to COVID-19 itself.

COVID will soon be endemic. This doesn’t mean it’s harmless or we give up, just that it’s part of life

Endemic doesn't mean we drop our guard, surrender to the virus or downgrade the threat the virus poses to individuals or the community.

The cognitive bias that tripped us up during the pandemic

Anchoring bias meant we found it hard to get rid of the first bit of information we heard.

COVID: WHO recommends two new treatments – here’s how they work

Sotromivab and baricitinib target COVID at different stages of its development, and will give doctors greater flexibility in treating Omicron patients.

"A big win-win": Vaccine sharing could protect against future COVID-19 waves

Modelling suggests that increased COVID-19 vaccine donations by wealthy nations could benefit rich and poor countries alike.

Uganda’s door-to-door polio campaign targets unimmunised children

Uganda is working hard to ensure that all the gains made in the fight against polio aren’t lost to the pandemic.

Nine factors that could boost your risk of Long COVID

Emerging research is shedding light on why some people are more likely to develop persistent symptoms after catching COVID-19 than others.

Fit for women: 5 things you need to know about global health, gender equality and PPE

Women make up 70% of the health workforce, yet personal protective equipment – or PPE – is still not being designed for them. A landmark conference held this week looked at solutions to the insidious gender bias putting female health workers’…

“Corona Warriors”: The Asha workers of Uttar Pradesh

Asha Workers are the backbone of rural health infrastructure in India. Since the pandemic began, they have been actively involved in educating and helping people cope with the effects of COVID19.

“Stealth Omicron”: Everything you need to know about the new BA.2 subvariant of SARS-CoV-2

A descendent of the Omicron variant called BA.2 could be more contagious, but it doesn’t appear to cause more severe COVID-19 disease.

Our lives won’t remain the same: Nigerians embrace COVID-19 vaccines

Once gripped by uncertainty and confusion, the increased availability of life-saving vaccines is helping more Nigerians break the cycle of fear that came with COVID-19.

Q&A: Religious minorities and ‘faith’ in vaccines

Nurturing confidence in vaccination among minority populations like the Haredim, a Jewish religious group sometimes problematically referred to as “ultra-Orthodox,” has a lot to do with listening, says medical anthropologist Ben Kasstan.

How the planes of the future will create a healthier planet

The effects of climate change may lead to future pandemics. As the aviation industry looks to the future, cleaner fuels and electric planes will be key to reducing aviation’s impact on the climate.

COVID: why some people with symptoms don’t get tested

Recent research found around a quarter of people with classic COVID symptoms didn't get tested.

Can Omicron evade detection from PCR, rapid antigen or lateral flow tests?

PCR and antigen tests are still reliable in detecting the new variant, although in the first few days saliva could be better than nose swabs at picking up the virus.

How Cameroon is making the Africa Cup of Nations COVID-safe

While there were concerns over the threat posed by COVID-19 at Africa’s premiere football tournament, host nation Cameroon is working hard to limit the spread.

We can stop the cycle of new variants continuing indefinitely with a pandemic vaccine pool

Without it we could face further delays in the global rollout and risk the gulf between the vaccine haves and have nots widening.

Workers at a Kenyan syringe company set the record straight

Workers from a syringe-making company in Kilifi, Kenya have been changing minds around the COVID-19 vaccine.

Seven reasons why trying to get ‘COVID over with’ is a bad idea

With more than half of all Europeans predicted to be infected with COVID-19 in the next two months, and perceptions of it being mild, it might be tempting to think it’s better to get the infection over with. Here’s why that is a dangerous game to…

Hail a jab: COVID-19 vaccines taken to the taxi ranks of Eswatini

Access to COVID-19 vaccines has been made easier in the Kingdom of Eswatini as residents can get their jab at bus stops and taxi ranks across the country.

Breaking COVID's Grip

COVAX and the other international organizations committed to vaccine equity cannot end the COVID-19 pandemic without the continued support of governments, industry, and civil society. By working together, the world has a chance to tame the…

The top 5 Omicron symptoms to be aware of

 As the Omicron variant of COVID-19 continues to spread around the world, here’s what you need to know about its symptoms.

Infectious period: Are cuts to COVID-19 isolation times a good idea?

Growing numbers of countries are cutting the isolation period for people who test positive for COVID-19, but what does the science say about how long people remain infectious for?

You need a plan: Successfully immunising zero-dose children in Nigeria

COVID-19 has hit routine immunisation hard in southern Nigeria. Authorities are now working hard to ensure children don’t miss out.

Pakistan reignites polio vaccination drive

Civil society, media, local influencers, celebrities, religious scholars, and frontline workers are all reinforcing the Pakistan government’s fight against Poliomyelitis.

Prioritise first doses of COVID-19 vaccines over boosters, say WHO experts

3.6 million people have still not had even their first dose of COVID-19 vaccine. Ensuring every adult has received at least one dose should be our focus for 2022.

India versus Omicron: How the country’s third COVID-19 wave might unfold

Daily COVID-19 cases have been rising fast, so how well protected is India’s population against Omicron?

Common cold could explain why some people never seem to get COVID-19

A recent cold is no substitute for a COVID-19 vaccine, but lingering immunity from one might protect a lucky few.

Here’s where (and how) you are most likely to catch COVID – new study

To discover your risk of catching coronavirus for any given situation, try our COVID-19 Aerosol Transmission Estimator.

How COVID-19 vaccines affect the menstrual cycle

Emerging evidence suggests that COVID-19 vaccination does impact menstrual cycle length – but the effect is minor and temporary.

Could the Omicron variant end the pandemic?

Omicron’s seemingly milder symptoms have prompted some to speculate that the COVID-19 pandemic is burning out. But low vaccination rates mean there could be plenty of obstacles ahead.

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19, with 21 vaccines now being rolled out in countries worldwide. Here is an at-a-glance overview of those vaccines and…

Omicron: Vaccines remain the best defence against this COVID-19 variant and others

Even with a variant like Omicron that might be more transmissible than earlier variants, vaccines remain the most effective tool for protection against COVID-19 and for ending the pandemic.

Delivering essential vaccines in Kenya’s nomadic Gosha community

Kenya is raising awareness about vaccines to reduce the number of zero-dose children who never receiving a single dose.

How COVID-19 transformed genomics and changed the handling of disease outbreaks forever

Revolutions in genome sequencing have been used to track COVID-19 in near real time.

Churches are boosting vaccination rates in Eswatini

Eswatini has launched a campaign to encourage members of the Zionist churches to get vaccinated against COVID-19.

Everything you need to know about “Flurona”

Influenza-coronavirus co-infections are increasingly being reported in the media, but how common are they, and should we be worried?

COVID healthcare costs ‘catastrophic’ for poorest

Health care costs push more than half a billion people into extreme poverty. COVID-19 adds to the burden, halting progress towards universal health coverage. Health policies must protect poor from financial hardship, say World Bank, WHO.

Is Omicron really less severe than previous COVID-19 variants?

Mounting evidence suggests the Omicron variant is associated with fewer hospitalisations and is less likely to infect the lungs. However, it remains a major threat.

Long Covid is Pitting Patients Against Doctors. That’s A Problem.

Health care professionals must act swiftly to ensure frustrated patients don’t fall victim to misinformation.

How Omicron could make other variants less dangerous

Research from South Africa has found another way in which Omicron could replace Delta and potentially make it less dangerous by boosting immunity to the latter variant.

COVID-19 means that Pakistani transgender people are even more marginalised

Trans rights organisations such as the Good Thinker Organisation are working to ensure that Pakistan’s transgender community recovers from the hardship that COVID-19 has wrought.

The impact of COVAX in Laos

Vaccination started off slow, but has steadily increased over 2021 thanks to public health messaging and vaccine deliveries.

How can scientists update coronavirus vaccines for omicron?

A microbiologist answers 5 questions about how Moderna and Pfizer could rapidly adjust mRNA vaccines.

Uganda: Taking vaccines to the people

The country is on a major vaccination drive to ensure that people are protected and the economy can recover.

12 Days of COVAX

All around the world, COVAX deliveries are helping to protect frontline health workers, reach nomadic communities, reunite families and allow schools to reopen. Since deliveries began in March, #VaccinesWork has been publishing snapshots that…

#VaccinesWork’s top 11 articles of 2021

2021 has been another tumultuous pandemic year. #VaccinesWork has been there through every twist and turn in our collective pandemic story, covering the latest science, bringing new perspectives from countries across the world and digging into…

Greetings from the North Pole to the Polarised North: street art Santa arrives in Germany

An expression of frustration with vaccine skeptics, German street artist and former immunologist Lapiz's new work is not your typical Christmas card.

How the public came together to support COVID-19 vaccines for the world’s most vulnerable

People around the world have demonstrated global solidarity by donating to the COVAX Facility, providing vaccines to those who would otherwise have no access.

Dr Seth Berkley's reflections on 2021 and the global imperative for 2022

2021 has been another challenging pandemic year, but despite the challenges it saw important milestones, extraordinary resilience in Gavi-supported countries and progress on a number of fronts. In his annual end of year letter, Gavi CEO Dr Seth…

Nigerian stars boost COVID-19 vaccination

Commanding a large following among music and movie lovers, some Nigerian entertainers are using their popularity to encourage fans to take the COVID-19 jab.

“We couldn’t afford to buy these vaccines on our own”: COVAX delivers in Malawi

COVAX deliveries have ramped up in Malawi, given local health workers and officials hope against the pandemic.

Not so super-immunity: People who’ve recovered from COVID-19 and vaccinated can still be reinfected

Israeli data suggests even those who’ve been double-jabbed or recovered from COVID-19 should take precautions to avoid infection.

COVID passes: they can’t prevent every infection but do make events safer

COVID passes lower the risk of transmission and incentivise vaccine uptake at a time when boosters are desperately needed.

T cell army: How infection-busting cells from previous coronavirus exposure could protect against severe COVID-19

While immunologists often focus on antibody responses to SARS-CoV-2, T cell immunity may hold the key to preventing severe COVID-19 disease.

How do the symptoms of Omicron differ from previous COVID-19 variants?

Reports that the Omicron variant may be associated with milder symptoms increase the need for vigilance and infection control.

How COVID-19 and Omicron are affecting travel this holiday season

Here's what you need to know about Omicron and traveling safely this holiday season.

Why excess deaths have varied so greatly around the world during the pandemic

How governments chose to respond to the coronavirus – and how well equipped their health services were before it arrived – made a big difference.

This little vaccine went to market: boosting vaccine uptake in Nigeria

From the market square in Oba, Benin City, vaccinators reach busy businesspeople with COVID-19 vaccines.

Kenya’s campaign to protect holidaymakers

As tourists flock to Kenya’s beaches after curfews were removed, the government is on a mission to ensure they’re protected with COVID-19 vaccines.

Malawi in 60-day COVID-19 “vaccine express” drive

Malawi’s Ministry of Health has embarked on a two months vaccination express campaign to drive uptake and take vaccines to the people.

From availability to arrival: How COVAX doses make it to countries

By the end of 2021, COVAX will have delivered approximately 800 million doses to 144 countries around the world – the largest and most complex vaccination rollout in history. But what exactly does it take for doses to arrive in countries?

How to talk to your children about getting their vaccine - an expert explains

Children might be unsettled by needles and vaccinations. However, vaccinations are an essential tool to stemming the spread of COVID-19. Here an expert explains what you can do to help alieviate children's concerns.

Omicron: What we know so far

Since being designated a variant of concern on 26 November, the Omicron variant has rapidly spread across the globe. The consequences of this are still unclear, but scientific data is now starting to emerge.

Tackling COVID disinformation with empathy and conversation

Living with someone who believes in anti-vaccination misinformation can tear families apart, say experts.

The Pandemic and Africa's Social Safety Net

The COVID-19 pandemic has shown that African tax and social-benefit systems are currently ill-equipped to protect households from sudden income losses. Meaningful progress will require policymakers to reduce the size of the informal sector and…

COVID-19 vaccines and pregnancy – here’s what you need to know

Many myths and rumours have spread around the impact COVID-19 vaccinations could have on pregnancy and fertility. The truth is far more reassuring.

We've had COVID-19 vaccines for one year. How can we make better use of them?

It has been one year since COVID-19 vaccines first became available in the UK. COVID-19 vaccines work well, but the question now is how can we make the best use of them? Getting first doses out to people in all countries has to become the…

How a mix-and-match vaccine approach could boost immunity to COVID-19

Signs are emerging that the way your immune cells encounter SARS-CoV-2 can have a lasting impact on how they respond to it in the future.

An ode to health workers on the highways of Monterrey, Mexico

Street artist Buffon draws attention to the importance of healthcare workers and how we can all play our part in ending the pandemic.

Togolese healthcare workers take on the odds to fight COVID-19

As the first line of defence against COVID-19, Togo’s healthcare workers are doing all they can to tackle the pandemic.

"The boys are back in town": Sports and entertainment return in Zimbabwe

There is a glimmer of hope for Zimbabwe’s sports and entertainment.

How COVID-19 led to devastating rises in malaria

The fight against the killer disease has nearly halved malaria deaths since 2000, but now that hard-won progress could be lost because of the pandemic.

This is how COVID-19 hit household expenditure in Europe

New data reveals that COVID-19 reduced Europe’s household spending by 8% in 2020. Nations with the severest lockdowns saw the most dramatic drop in household consumption, says Eurostat. Elsewhere, consumer spending in China fell by 17% in 2020.…

Galápagos census looks at impacts on turtles during and after COVID lockdown

The suspension of tourism activities around the world as a result of the COVID-19 pandemic gave researchers the chance to answer an important question: What impact does tourism have on wildlife populations?

From Alpha to Omicron: Everything you need to know about SARS-CoV-2 variants of concern

All viruses change over time, and SARS-CoV-2 is no exception. Here’s what we know about the current variants circulating globally at the current time.

Omg, Omicron! Why it’s too soon to panic about COVID vaccines and the new variant

We won't know whether Omicron evades COVID vaccines for another few weeks. Here's why.

When will life return to normal after the pandemic?

Surveying by the Office for National Statistics shows Brits are increasingly pessimistic about things returning to how they were before.

A Ghanaian doctor’s perspective on COVID-19 vaccine inequity

Pre-COVID-19, Ghana’s health system was overburdened. The virus has made everything harder, and vaccine inequity has made it harder still.

Growing viral: health, hope, and happiness in the time of COVID and HIV

Living with one lethal virus, the children of Snehagram in southern India bolster each other in surviving the coronavirus pandemic.

Mask wearing wasn’t disputed in previous crises – so why is it so hotly contested today?

How the pandemic is reported by the media can influence people's behaviour.

How next-generation COVID-19 vaccines could help to end the pandemic

A year ago, we had no COVID-19 vaccines, now we have many. Could the next generation of vaccines be better still?

The hunt for coronavirus variants: how the new one was found and what we know so far

There's a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants.

There's Only One Way to Stop the Emergence of Variants Like Omicron

"This crisis is far from over, and without dramatic course correction, will go on for some time."

Omicron: why the WHO designated it a variant of concern

Not much data, but lessons have been learned from the slow response to delta.

Journalists fighting the pandemic: Cameroon's COVID-19 unsung heroes

The media men and women in the country are doing their all to reverse this phenomenon.

The Future of Global Pandemic Security: Navigating shifting landscapes – a Gavi White Paper

The COVID-19 pandemic has demonstrated how ill-prepared health systems and societies are in the face of pandemic shocks and their protracted impact. Now, as global attention begins to shift towards improving the way we prevent and respond to…

What do we know about the new B.1.1.529 coronavirus variant and should we be worried?

The variant was first detected in Botswana and contains a high number of mutations associated with increased immune evasion.

Study: government vaccine spending increases since 2000

A comprehensive analysis of vaccine spending shows that while lower-income country governments take on the bulk of financing, they need to mobilise greater resources for immunisation.

We expected people with asthma to fare worse during COVID. Turns out they’ve had a break

Not only have asthma attack rates decreased during the pandemic, evidence suggests people with asthma are not at increased risk of severe outcomes from COVID.

COVID-19 and the impact on part time jobs

The loss of jobs during the pandemic was experienced almost exclusively among part-time jobs. Research shows it is likely that demand for workers in hard-hit sectors will start to come back, writes economist Jonathan Wadsworth. However, the…

COVAX slot swapping: Explained

Switzerland has just become the first country to trade places with COVAX in manufacturers’ supply queues, making one million doses of Moderna’s COVID-19 vaccine available to the Facility. But what is slot swapping and why is it necessary?

Immune to COVID-19: Why some people test negative when everyone around them is testing positive

Researchers are closing in on why some people are apparently more resistant to COVID-19 infection.

Why COVID-19 Misinformation Works

The rampant spread of false information about the coronavirus has been attributed to politicians who have promoted remedies ranging from anti-malarial drugs to herbal drinks. But how humans process knowledge has an important role to play in…

South Sudan launches mandatory testing and vaccination

There are differing views on whether mandatory testing and vaccinations will improve COVID-19 vaccine uptake.

How Peru became the country with the highest COVID death rate in the world

The country moved quickly to contain the virus, but its health system struggled to look after those who got sick.

COVID-19 vaccines: Nepal leaves no people with disability behind

"Leave no one behind" has been one of the core pledges of the SDG 2030 agenda. In light of the COVID-19 situation, it is vital to consider the plight faced by people with disability. Nepal has lessons for us all.

Slipping through the cracks: Urban under-immunisation on Bengaluru’s margins

In 2020, 16 million children in lower-income countries did not receive the third dose of their basic childhood vaccines. 12.4 million of them didn’t even receive their first dose. Despite a perception that missed children typically belong to hard…

Young and ethnic minority workers were hardest hit at the start of COVID, but not anymore

The two groups bounced back more quickly in the jobs market than certain other groups, although they may still experience lasting consequences.

Hospital waste, not masks, are plastic scourge of pandemic: Study

A new study has found that 26,000 metric tons of pandemic-related plastic waste has been released into the world’s oceans since the start of the COVID-19 pandemic in January 2020.

Traditional governance systems help turn the tide against COVID-19 in Kenya

A century-old system of governance has helped keep their land plentiful and their villages peaceful. Now elders in Isiolo County, central Kenya, are using the system to keep their villages free of COVID-19.

Claims that COVID jabs can be used to track you with ‘luciferase’ are false – the substance isn’t even in the vaccine

Luciferase is a useful tool in medicine and has nothing to do with Satan.

Is this the great vaccine-mandate resignation that wasn’t?

COVID-19 vaccine mandates have spurred protests and resignations. But the evidence so far points to marginal workforce losses. Evidence also suggests that mandates keep people safe and save lives.

My shampoo stinks of vomit: How COVID-19 can mess up your sense of smell

Increasingly, people who are recovering from COVID-19 are reporting a distorted perception of odours, also known as parosmia.

Why having bad oral health could raise the risk of COVID

Badly controlled bacteria in the mouth pose multiple risks.

Kenya’s weak link in the fight against COVID-19

On 7 October Kenya launched an ambitious campaign to vaccinate over a million operators in the public transport sector.

How disease has stimulated cultural change

Laws and rituals surrounding disease have been part of everyday life for millennia. Here's why that's important.

Would you get vaccinated in a bank? Mobile vaccination clinics take off in Nigeria

Businesses and corporate organisations are making special arrangements to protect workers and, by extension, customers through mobile vaccination.

History’s Seven Deadliest Plagues

SARS-CoV-2 has officially claimed 5 million lives, but credible estimates place the pandemic’s true death toll closer to 17 million. Either count secures COVID-19’s position on our list of history’s deadliest plagues. 

What pneumonia can teach us about COVID-19

COVID-19 still has many unknowns, but hope lies in what we already know about preventing and treating pneumonia.

Two-strike Ebola vaccine enters human trials

The vaccine, which is based on the Oxford/AstraZeneca COVID-19 vaccine, is designed to target both the Zaire and Sudan species of Ebola virus.

Investments in Disease Surveillance Support Kenya’s Response to COVID-19

In a conversation with Maria Deloria Knoll, PhD, IVAC’s Director of Epidemiology, Dr. Kagucia shared how Gavi-supported activities facilitated Kenya’s COVID-19 response by expanding capacity, testing, and partnerships.

Lagos steps up the fight against COVID-19

Lagod – the epicentre of COVID-19 in Nigeria – is ramping up its vaccination campaign, with committed leaders and ambitious targets.

Can vaccines unlock access to health care?

Zero-dose children who never receive a single vaccine are also more likely to miss out on crucial primary health care services.

Discoveries from vaccine implementation

In episode 8 of the Global Health Matters podcast, we spoke to Professor Margaret Gyapong of the University of Health and Allied Sciences in Ghana and Dr Lee Hampton of Gavi, the Vaccine Alliance. These experts shared their views on how…

Sickness and survival in pre-COVID-19 Nepal

A gripping documentary about a family's struggle with the emotional and financial consequences of severe pneumonia.

Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines

The development of COVID vaccines has already been explosive. There are more innovations on the way.

White-tailed deer found to be huge reservoir of coronavirus infection

In a sample of white-tailed deer, 80% were found to have an active COVID infection.

Q&A: Dr Collins Tabu, Kenya’s immunisation chief, discusses the COVID-19 vaccine roll-out

Dr Collins Tabu, Head of Kenya's National Vaccines and Immunisation Program, is on a mission to vaccinate at least half of the adult population against COVID-19 by the end of the year. #VaccinesWork spoke to him to see how they plan to do it.

COVID-19 vaccines: from rejection to shortage, how Côte d’Ivoire became a model for managing vaccine hesitancy

In February 2021, Côte d’Ivoire’s efforts to vaccinate its population in order to save lives and stem the spread of the coronavirus were being stymied by a wave of misinformation and a low level of public acceptance of the vaccine.

Vaccine rollout steps up a gear in Sierra Leone

Just 5.5% of Sierra Leoneans have had their first COVID-19 vaccination. With a target to reach at least 80% by December the campaign, with support from COVAX, is ramping up.

Five crucial years, one unprecedented new pandemic and 324 million children immunised

Even with the adversities and challenges of the COVID-19 pandemic through 2020, Gavi maintained unyielding focus on leaving no one behind.

COVID-19 vaccinations help restore family links in Kenya’s prisons

Inmates in Kenya’s prison system have been banned from seeing family members for over a year and a half. A vaccination campaign.

Vaccine profiles: Haemophilus influenzae type b (Hib)

Before immunisation for Hib became routine, it was one of the biggest killers of children under five and the main cause of meningitis. High vaccine coverage is essential to keep that threat at bay, especially given rising antimicrobial resistance…

Protecting prisoners in Malawi

Malawi prisoners are at higher risk of getting COVID 19; vaccines are helping to contain the spread.

COVID could wreak havoc on gorillas, but they social distance better than we do

Endangered mountain gorillas in Rwanda’s famous Volcanoes National Park could face “population collapse” within 50 years if some of them contract COVID-19, new research suggests.

COVID-19 wreaks havoc on the Kenyan entertainment industry

While there are those who have thrived, for most entertainers in Kenya COVID-19 came close to decimating the sector.

Q&A: Designing a shock-proof health system

How do we ensure resilient health systems and immunisation programmes that can bounce back from future health threats? In this Q&A with Gustavo Correa, Gavi’s Senior Manager for Data systems and Information, and Josh Wunderlich, Gavi…

Doctors, scientists or politicians: who are you most likely to trust after the pandemic?

Doctors are rated as trustworthy by almost two-thirds of people, according to the Ipsos Global Trustworthiness Index 2021. Scientists came in second, at 61% and teachers third, at 55%. How to restore trust is a key and growing theme for…

Without global vaccination, all COVID immunity is at risk

A year from now, instead of potentially entering the pandemic endgame, we could find ourselves at the start of a new and perpetual cycle of revaccination or boosters for people who have already previously been protected.